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ABSTRACT 
Background: Sleep disturbance, including insomnia disorder, is common among 
patients with chronic health conditions, and is associated with psychological 
difficulties and impaired health-related quality of life (HRQoL). Less is known about 
whether a similar relationship exists in individuals with chronic health conditions 
who do not have a clinical diagnosis of sleep disturbance (NCSD). Recent evidence 
suggests that Cognitive Behavioural Therapy (CBT) in the form of self-help (SH) is 
an effective treatment for individuals with chronic health conditions and has the 
advantage of low cost and ease of access. Any form of sleep disturbance may be 
perceived as problematic for individuals with chronic health conditions. This study 
aims to: a) examine whether the NCSD population with chronic health conditions at 
baseline have poor sleep quality, insomnia symptoms, high levels of psychological 
distress (anxiety, depression and stress), sleep-related dysfunctional beliefs and 
impaired HRQoL, and b) assess the effectiveness of the CBT-SH booklet.  
Method: Participants were recruited from outpatient clinics and received a 6-week 
CBT-SH booklet for sleep-related problems. Outcome measures included evaluations 
of subjective sleep quality and the severity of insomnia symptoms, psychological 
distress (anxiety, depression and stress) sleep-related dysfunctional beliefs and 
HRQoL. Measures were completed before and after the intervention.  
Results: Forty-nine participants (44 females) completed the study. Prior to the 
intervention, 46 participants reported poor sleep quality and 47 participants reported 
clinical or subthreshold insomnia. Mean scores for the measures of psychological 
distress indicated moderate levels of anxiety, depression and stress and sleep-related 
dysfunctional beliefs respectively. HRQoL was also impaired. Following the CBT 
intervention, participants showed significant improvements in sleep outcomes, sleep-
related dysfunctional and stress levels. No significant differences were found in 
HRQoL depression and anxiety outcomes.   
Conclusion: A brief CBT-SH booklet for sleep-related problems is effective for 
patients with chronic health conditions and NCSD in clinical settings. 
 
Key words:  sleep disturbance; sleep quality; chronic health conditions; cognitive 
behavioural therapy; self-help.   
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1. Introduction 
 
This study concerns a Cognitive Behavioural Therapy (CBT) based intervention in 
the form of a self-help booklet for a clinical population with a self-reported sleep 
disturbance problems. In order to establish the context of the current study, the 
subsequent chapter begins by addressing and defining the most important key terms 
of the related literature of relevance to the current study in order to aid understanding 
of the theoretical framework and empirical research of the study.  
Firstly, it provides an understanding of the nature of sleep disturbance, followed by 
an overview of insomnia, which is the most common sleep disorder that may coexist 
with or without medical or psychiatric disorder. Subsequently, the current review 
provides the background of a number of chronic health conditions and their 
documented link with sleep-related problems. Furthermore, it reviews the evidence 
for the factors contributing to and maintaining sleep problems in patients with 
chronic health conditions as well as the negative consequences of sleep-related 
problems on the individual’s quality of life.  
Secondly, it provides an overview of the vast treatments available in managing sleep 
problems such as pharmacological, complementary or alternative therapies (e.g. 
herbal remedies), behavioural and psychological therapies along with their scientific 
evidence for managing sleep problems. Emphasis on the management of sleep 
problems is given to the behavioural and psychological therapies and, in particular, 
to CBT for sleep-related problems.  
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2. LITERATURE REVIEW 
 
 
2.1. The nature of sleep disturbance research  
 
Initially sleep was considered a passive or dormant activity in our daily lives 
whereas, today, it is considered an active physiological process, since our brain is 
active during sleep (American Sleep Association, 2015). Sleep is considered as an 
essential need for a healthy life and overall well-being, (National Sleep Foundation 
(NSF), 2015), since it affects physical and mental health (American Sleep 
Association, 2015). Subsequently, good sleep is fundamental for a healthy life 
(Buysse, 2014).  
Both quantity and quality are important for good sleep (NSF, 2015). Poor sleep 
quality is a clinical construct, since sleep quality disturbances are common and poor 
sleep quality may be the result of a sleep disorder or a medical disease (Buysse et al., 
1989). Buysse et al. (1989, p.194) consider sleep quality to be a ‘complex 
phenomenon that is difficult to define and measure objectively’. The quality of sleep 
can be measured quantitatively – by measuring sleep duration, sleep latency or sleep 
arousal – or qualitatively by measuring the subjective ‘depth’ or ‘restfulness’ of sleep 
(Buysse et al., 1989).  
 
 
2.1.1. Sleep Disturbance Classified as Insomnia  
 
Insomnia is the most prevalent sleep disorder encountered among adults of any age 
(National Institute of Health (NIH), 2005) and the second most common health 
complaint after pain (Morin, 1993). Thus it has received considerable attention in the 
existing literature. Insomnia is defined as disturbed sleep under conditions, which are 
conducive to sleep. The disturbance may manifest itself in a number of ways, 
including one or more of the following: 1) difficulty in initiating (sleep-onset), 2) 
difficulty in maintaining sleep, or 3) waking prematurely. Nonrestorative or poor 
sleep can also be included in this definition (NIH, 2005).  
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In terms of its duration, insomnia may be classified as acute insomnia and chronic 
insomnia (e.g. 6 months or one month or more) (NIH, 2005). Also, insomnia can be 
characterised as primary insomnia (PI) when no existing disorder has been identified 
and secondary insomnia (SI), the result of a medical, psychiatric condition or a 
substance (McCrae & Lichstein, 2001a). Despite their causal differences, both 
primary and secondary insomnia share similar features in terms of their definition 
(McCrae & Lichstein, 2001a). The NIH (2005) suggested a terminology-related shift 
from ‘secondary insomnia’ to ‘comorbid insomnia’ because, on the one hand, the 
direction of causality between condition and insomnia is unclear and, on the other 
hand, the term ‘secondary insomnia’ may result in under-treatment. Therefore, it may 
be concluded that individuals with chronic health conditions and sleep problems 
warrant independent treatment for sleep-related problems.  
 
Studies in the field of sleep have mainly used clinical diagnostic criteria for insomnia 
or for comorbid insomnia and/or other structured screened interviews or various 
insomnia severity measurements to diagnose or assess individuals with clinical sleep 
disorder (e.g. insomnia). In contrast, the current study used a pragmatic, real-world 
approach in terms of defining and confirming sleep-related problems among patients 
with chronic health conditions.  
Since it is possible that any form of sleep disruption may, to some degree, have an 
effect on an individual with chronic health conditions, the current study relied on 
individuals’ self-reporting sleep-related problems or sleep disturbance and, for the 
purposes of this thesis, insomnia and sleep disturbance are not differentiated since 
they are not clinically evaluated or diagnosed and therefore the term ‘non-clinical 
sleep disturbance’ (NCSD) is utilised (e.g. individuals who report sleep disturbances 
which are not clinically established like insomnia but which, nonetheless, may be 
perceived as problematic). In particular, this approach was preferred in order to keep 
the current study as close as possible to the real-world context, since sleep 
disturbance is a very broad term that may have different meanings for different 
people.  
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In general, sleep disturbance may refer to any real disruption in sleep patterns and a 
brief and effective treatment may prove to be beneficial to patients, despite the 
severity of the sleep problem.  
Until recently, no studies had examined NCSD in patients with chronic health 
conditions and no studies had examined specifically the effectiveness of CBT-I in the 
form of a self-help (SH) booklet in a NCSD population with at least one chronic 
health condition who self-reported sleep-related problems. Therefore, based on this 
observation, the purpose of the current study is to assess the effectiveness of the 
CBT-I SH booklet for patients with chronic health conditions and with NCSD. 
However, before doing so, it is important to understand the aetiology of the different 
factors in affecting and maintaining insomnia.  
 
 
2.1.2. The Aetiology of Insomnia  
 
There is no agreed understanding of the mechanisms contributing to the 
pathophysiology of insomnia (Edinger & Means, 2005). Spielman (1986; Spielman 
& Glovinsky, 1991) proposed a behavioural model known as the ‘3P-model of 
insomnia’, which was further expanded by Morin (1993).   
This model describes three different factors that operate in the development and 
maintenance of insomnia: 1) predisposing conditions or long-term traits (e.g. 
arousability, family history or genetic traits, gender); 2) precipitating factors (myriad 
stressful life events, such as work, divorce, death and illness such as uncontrolled 
symptoms such as pain fatigue, etc.); and 3) perpetuating factors (e.g. maladaptive 
behaviours and cognitive misrepresentations) that maintain or exacerbate insomnia 
(Morin, 1993).  
Morin (1993) in particular suggests that insomnia can be viewed as an interaction 
between arousal (e.g. emotional, cognitive, physiological), dysfunctional cognitions 
(e.g. worry, rumination, unrealistic expectations, misattributions/amplifications), 
maladaptive habits (e.g. excessive time in bed, napping, sleep-incompatible 
activities, irregular sleep schedule) and concerns about consequences (e.g. mood 
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disturbance, fatigue, social discomfort). The relationship among these different 
factors is bi-directional (Morin, 1993).   
In sum, the 3-P model of insomnia suggests that various factors, to different degrees, 
may play a role in increasing the likelihood of an individual developing sleep 
disturbance. Precipitating factors, such as stressful events, may disturb sleep but the 
predominant factors that maintain chronic insomnia are perpetuating factors (e.g. 
cognitions and maladaptive sleep habits) (Morin, 1993). Consequently, the 3-P 
model provides the theoretical framework for understanding how patients with 
chronic health conditions may be engaged in the perpetuating factors that maintain 
sleep problems. However, very little is known about non-clinical sleep disturbance, 
its impact and suggested treatments to alleviate its outcomes, hence the current study, 
aims to address this gap in the literature.  
 
 
2.1.3. Measuring sleep disturbance insomnia symptoms and treatment 
outcomes  
  
Any study requires reflection on measurement and in the field under consideration, 
there is a range of tools that are used to measure sleep disturbance, including both 
objective and subjective self-reporting measures (Buysse, Ancoli-Israel, Edinger, 
Lichstein & Morin 2006; Menefee et al., 2000).  
 
 
2.1.3.1. Objective methods  
 
Polysomnography (PSG) is an objective measurement, which is mainly used in the 
screening and assessment of sleep disturbance (Buysse et al., 2006). This particular 
type of objective measurement can be used at home or in the lab, and is considered 
the most sensitive method for distinguishing wakefulness from sleep (NIH, 2005). 
Though, PSG is not a cost-effective method (NIH, 2005; Menefee et al., 2000).  
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A different objective method is actigraphy, which can be used to provide an exact 
measure of global sleep parameters (e.g. total sleep/wake time and time in bed) 
(Morin, 2003). Evidence suggests that actigraphy is an acceptable and reliable 
method for measuring the duration of sleep (Petit, Azad, Byszewski, Sarazan, & 
Power, 2003).  
 
 
2.1.3.2. Subjective methods  
 
Subjective methods include various types of self-reporting measures that assess sleep 
disturbance (Pigeon, 2010a). The most commonly used measures, with established 
reliability and validity, are the Pittsburgh Sleep Quality Index (PSQI), which 
measures the overall sleep experience by distinguishing poor sleepers from good 
sleepers (Buysse et al., 1989) and the Insomnia Severity Index (ISI), which assesses 
insomnia severity (Bastein, Vallieres & Morin 2001) (Pigeon, 2010a).  
Alternative subjective tools include sleep diaries or sleep logs  (e.g. recording sleep 
habits such as time to bed, minutes to fall asleep, number and duration of awakenings 
etc. for at least two weeks prior to therapy, throughout and at end the of the 
treatment)  (Pigeon, 2010a; Petit et al., 2003). Sleep diaries have less sensitivity to 
recall bias (Buysse et al., 2006) and are considered the most beneficial subjective 
tools in measuring sleep problems (Petit et al., 2003;Pigeon 2010a).  
 
In general, the different methods of assessing sleep disturbances have their own 
strengths and limitations. Self-report questionnaires form the basis of assessment 
measures in insomnia research because they are the main tool used by clinicians for 
treating patients with insomnia, they are cost-effective (Moul, Hall, Pilkonis & 
Buysse, 2004) and can be easily administered (Morin, 2003; Menefee et al., 2000) 
and scored (Morin, 2003). In addition, as discussed, subjective self-reports are an 
important assessment tool, because insomnia is a subjective complaint, and an 
individual’s perceptions of treatment efficacy are more valid than objective 
measurements (Martin, Shochat, & Ancoli-Israel, 2000).  
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On the other hand, in general, subjective methods require more resources and less 
cost-effective in assessing sleep of assessing sleep (Menefee et al., 2000).  
 
In summary, validated and reliable methods for measuring sleep problems are 
essential, since insomnia is a subjective complaint and sleep quality can only be 
measured using self-reports. In addition, self-report measures are the easiest and 
most convenient method of assessing sleep-related problems and self-report 
measures also fit well within the real world context. Therefore, self-report 
questionnaires are used in the current study.  
Insomnia and sleep-related problems in general are prevalent health problems among 
patients with various chronic health conditions and are associated with emotional 
distress and poor quality of life. The section below provides a further understanding 
of the relationship between chronic health conditions and sleep problems.  
 
 
2.2. Chronic Health Conditions and Sleep Disturbance  
 
One of the most important reasons for investigating non-clinical sleep disturbance is 
the well-established link between chronic health conditions and sleep-related 
problems, in particular insomnia.  
A chronic health condition or long-term condition (LTC) is defined by the UK 
Department of Health (2010) as a condition that cannot be cured, though it may be 
controlled by pharmacological treatments or other types of therapies. Approximately 
17.5 million individuals have a chronic health conditions in the UK, with a higher 
prevalence in the older population (>75 years old) (Department of Health, 2001).  
Moreover, chronic health conditions are more prevalent among the more 
socioeconomically deprived and the incidence of multi-morbidity (developing three 
or more chronic health conditions) is expected to rise in the ageing population 
(Department of Health, 2012).  
Patients suffering from common chronic health conditions often complain of sleep-
related problems (Shapiro, Devins & Hussain, 1993; Parish, 2009) such as having 
fewer hours of sleep and more unrefreshing sleep than healthy individuals, which in 
turn may trigger the symptoms of their illness (e.g. sleep complaint increases the 
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intensity of pain) (Parish, 2009). In a literature review on chronic insomnia, 
Ancoroli-Israel (2006) found that people with chronic health conditions usually 
experience sleep maintenance difficulty instead of sleep onset latency (e.g. difficulty 
falling asleep). Evidence suggests that insomnia rates are higher in people with 
medical and psychiatric conditions than in the general population (Katz & 
McHorney, 1998; Taylor et al., 2007).  
 
Also, studies have examined the association between sleep problems (e.g. insomnia) 
and various chronic health conditions. For example, Foley, Ancoli-Israel, Britz, and 
Walsh (2004) examined the association between sleep-related problems and eleven 
different types of chronic health conditions (e.g. depression, heart disease, 
hypertension, arthritis, diabetes, osteoporosis, cancer etc.) in older adults (aged 55-84 
years old) who have self-reported every night, or almost every night sleep-related 
problems (e.g. difficulty falling asleep, waking up too early, failing get back to sleep, 
feeling unrefreshed, experiencing breathing difficulties, having unpleasant feelings in 
the legs, etc.). The results showed that 83% of the participants had multi-morbidity 
of chronic health conditions (i.e. one or more chronic health condition) and about 
25% of elderly adults (e.g. aged 65-84 years old) had four or more comorbid 
conditions. The findings also showed that different types of chronic health conditions 
are associated with different sleep problems. For example, patients suffering from 
heart disease, depression, pain and memory problems had symptoms of insomnia, 
whereas patients with obesity, diabetes, osteoporosis, arthritis, etc. experienced 
breathing pauses, daytime sleepiness, snoring or restless leg sleep-related problems. 
Furthermore, the authors concluded that sleep problems occur due to chronic health 
conditions and not to ageing per se.  
Further evidence of this association is provided by Sutton, Moldofosky and Badley, 
(2001). They found that insomnia was related to particular types of chronic health 
conditions such as circulatory, rheumatic diseases, digestive and respiratory diseases, 
allergy and migraine) whereas age was not associated with insomnia. Also, a more 
recent community-based study found that insomnia was associated with a wide range 
of chronic health conditions. In particular, individuals with insomnia reported more 
heart disease, chronic pain, gastrointestinal problems, hypertension, breathing 
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difficulties, neurologic and urinary problems compared to individuals without 
insomnia (Taylor et al., 2007). Overall, these studies indicate that sleep-related 
problems are associated with various types of chronic health conditions.  
 
In addition, the association between insomnia severity and comorbid chronic health 
conditions is well established in the research literature. For example, Katz and 
McHorney (1998) found that 16% of patients with chronic health conditions had 
severe insomnia and 34% had mild insomnia, whereas the remaining 50% of patients 
had sleep disturbance symptoms without meeting the study’s criteria for insomnia. 
Katz and McHorney (1998) also found that the prevalence of both severe and mild 
insomnia endured, with 59% and 88% (with mild and severe insomnia respectively) 
of patients with chronic health conditions continuing to experience sleep problems at 
the 2-year follow up. However, like Foley et al. (2004) and Sutton et al. (2001) they 
found no significant association between insomnia and age.  
Similarly, a more recent study that examined the association between insomnia 
severity and comorbid chronic health conditions showed that increased insomnia 
severity is independently correlated with an increased chronic health condition after 
controlling for psychiatric illnesses and psychiatric comorbidities (Sarsour, Morin, 
Foley, Kalsekar  & Walsh, 2010). In addition, consistent with the research described 
above, evidence based on a review also suggests that people suffering from various 
chronic health conditions experience more severe and persistent symptoms of 
insomnia compared to people without chronic health conditions (Ancoroli-Israel, 
2006).  
 
Generally, these findings underline the association between sleep-related problems, 
insomnia and chronic health conditions and suggest that insomnia and other sleep-
related problems are persistent in individuals with chronic health conditions. 
Evidence also suggests that patients with chronic health conditions are at greater risk 
of insomnia, although, due to the nature of the data, it is not possible to imply 
causality; therefore the relationship between sleep-related problems or insomnia and 
chronic health conditions is considered bi-directional.  
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Furthermore, various chronic health conditions may disturb sleep in different ways 
(McCrae & Lichstein, 2001b). Thus, the aetiology of insomnia based on the 3-P 
model (Spielman, 1986; Spielman & Glovinsky, 1991; Morin, 1993) as discussed 
previously (see section 2.1.2), can provide a theoretical framework for understanding 
the various factors that may contribute to and maintain sleep problems, and for 
selecting the best treatment for patients with chronic health conditions and sleep 
problems.  
As such, the following sections review the most significant factors that may affect 
sleep problems in patients with various chronic health conditions that are considered 
the most relevant to the current study and to the treatment implemented in this study.  
Although, so far, the majority of evidence is based on patients with insomnia or other 
sleep-related problems, it is unclear whether there is a similar link between chronic 
health conditions and non-clinical sleep disturbance. Consequently, the current study 
will further explore this but first, it is critical to explore the psychological impact of 
living with sleep-related problems and chronic health conditions.  
 
 
2.3. Factors contributing to and maintaining sleep problems in chronic 
health conditions  
 
There are many major concerns in the lives of individuals living with sleep 
disturbance including pain, depression, anxiety and stress symptoms, as well as 
sleep-related dysfunctional beliefs, maladaptive sleep habits and poor health quality 
of life. These areas will be considered and reviewed separately below.   
 
 
2.3.1. Pain   
 
Individuals with different chronically painful physical conditions (CPPCs) frequently 
experience sleep disturbance (Moldofsky, 2001; Smith & Haythornthwaite 2004; 
Ohayon, 2005). Some common CPPCs are irritable bowel syndrome (IBS), 
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headache, rheumatic diseases (e.g. arthritis, osteoarthritis), non-musculoskeletal 
disorders (e.g. back pain), somatoform disorder and fibromyalgia (Moldofsky, 2001).  
For example, Ohayon (2005) examined the relationship between insomnia and 
different CPPCs in community-based populations from five different European 
countries, including the UK, and found that 40.2% of people with insomnia 
symptoms had at least one CPPC and also that CPPCs were related to the difficulty 
or inability to sleep again after being awake, and they had a shorter duration of sleep.  
Another study among older patients with chronic health conditions found that daily 
bodily pain is related to symptoms of insomnia, unpleasant feelings, daytime 
sleepiness, etc. (Foley et al., 2004).  
Power, Perruccio and Badley (2005) found pain to be a partially mediating factor in 
patients with arthritis and sleep problems. Moreover, the same study indicates that 
patients with arthritis but without pain reported higher insomnia symptoms compared 
to individuals without arthritis (17.1% vs. 9.4%). The authors also have controlled 
for other factors that may influence sleep, such as other chronic health conditions, 
sociodemographic characteristics and depression and stress factors and, therefore, 
they stated that it is unknown what other factors might influence sleep in patients 
with arthritis (Power, Perricio & Badley, 2005).  
The relationship between pain and sleep may be characterised as bi-directional, since 
pain may affect sleep and vice versa (e.g. Moldofoski, 2001; Smith & 
Haythornthwaite, 2004).  
 
Taken together, such evidence supports the idea that pain is associated with sleep 
difficulties, or pain may be a mediating factor and/or other factors may influence 
sleep problems, particularly in patients with arthritis. Also, the nature of the 
relationship between pain and sleep difficulties is unclear (e.g. does pain causes sleep 
disorder and/or vice versa?). Since sleep-related problems are prevalent among 
individuals with CPPCs, the current study includes participants with CPPCs. 
However, because pain was not the focus of the study, it was not targeted as an 
outcome of the treatment intervention used here.  
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2.3.2. Depression, Anxiety and Stress  
Evidence suggests that various chronic medical conditions are associated with 
anxiety (Clarke & Currie, 2009; Harter, Conway & Merikangas, 2003; Scott et al., 
2007) and depression  (Clarke & Currie, 2009; Patten, et al., 2005; Scott et al., 2007). 
In particular, Smith Huang, and Manber (2005) suggest that patients with CPPC are 
more susceptible to depression and anxiety, mainly due to the physiological effects 
of the illness and its influence on their quality of life. Also, psychological factors are 
shown to be associated with sleep disturbance in patients with chronic health 
conditions (e.g. type 2 diabetes, myocardial infarction, affective or rheumatic 
disorders, chronic paraplegia) (Hyyppa & Kronholm, 1989).  
 
Furthermore, the relationship between insomnia, depression and anxiety is widely 
known, since insomnia is a symptom of depressive disorder (NIH, 2005; Mai & 
Buysse, 2008) and generalized anxiety (Mai & Buysse, 2008). Individuals with 
insomnia may not meet the criteria for a major depression disorder or generalised 
anxiety. However, many individuals with insomnia report anxiety and/or depression 
(Morin, 1993). Evidence also indicates that the relationship between sleep-related 
problems (e.g. insomnia, sleep disturbance) depression (Sivertsen et al., 2012; 
Jansson-Frojmark & Lindblom, 2008; Spoormarker & van de Bout, 2005), and 
anxiety (Jansson-Frojmark & Lindblom, 2008; Spoormarker & van de Bout, 2005) is 
strongly bi-directional, as consistent with the findings from the pain research.  
 
Further evidence suggests that insomnia may lead to mental health problems such as 
depression and anxiety (Ford & Kamerow, 1989; Bresleau, Roth, Rosenthanl, 
Andreski, 1996; Taylor, Lichstein & Durrence, 2003; Baglioni et al., 2011).           
For example, a recent meta-analysis based on longitudinal epidemiological studies of 
the general population concluded that participants with sleep-related problems (such 
as insomnia symptoms e.g. difficulties initiating, maintaining sleep and non-
restorative sleep) but with no depression have twice the risk of developing 
depression than those without insomnia symptoms (Baglioni et al., 2011).  
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Also, a community-based study shows that there is a strong association between 
depression, anxiety and insomnia. For example, a cross-sectional study by Taylor, 
Lichstein, Durrence, Riedel and Bush (2005) (with a combined n=722) after 
controlling for confounding variables (e.g. gender and ethnicity, organic sleep 
disorder or medical disorders) showed that people with insomnia had higher levels of 
depression and anxiety compared to those without insomnia as measured by the Beck 
Depression Inventory (BDI; Beck, Ward, Mendelson, Mock & Erbaugh, 1961) and 
State Trait Anxiety (STAI; Spielberger, Gorsuch, & Lushene, 1970) respectively.  
In addition, a study of patients with multiple sclerosis (MS) found that depression 
and sleep disturbance, as measured by PSQI, are strongly associated (Merlino et al., 
2009). Furthermore, an earlier study found a strong association between depression 
and insomnia in patients with various chronic health conditions (Katz & Horney, 
1998). On the other hand, Morin, Gibson & Wade’s  (1998) study of patients with 
chronic pain found that poor sleepers reported slightly higher levels of anxiety and 
depression compared to good sleepers with chronic pain. However, the two groups 
did show statistically significant differences in anxiety and depression outcomes.  
The authors suggest that sleep disturbance is not certainly correlated with emotional 
disorder (Morin, Gibson & Wade, 1998). These findings are important, since they are 
not in line with previous studies that support the association between poor sleep 
quality, anxiety and depression.  
 
With regard to the type of measurement in assessing depression and anxiety in 
individuals with insomnia, the BDI (Beck et al., 1961) or the Inventory of Depressive 
Symptomatology self-report (IDS-SR; Rush, Guillion, Basco, & Jarret, 1996; Trivedi 
et al., 2004) and STAI (Spielberger et al., 1970) measurement for anxiety are the 
main assessments in accordance with recommendations for standardized research 
assessment in a population with insomnia (Buysse et al., 2006).  
 
Besides, stress is the most common precipitating factor in sleep disturbance (Morin, 
1993; Morin, Rodrigue & Ivers 2003). For example, an early study by Healey et al. 
(1981) found that poor sleepers experience more stressful life events during the onset 
of insomnia compared to good sleepers and the occurrence of stressful events is 
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greater in comparison with previous or following years. Furthermore, a more recent 
study found that individuals with insomnia compared to good sleepers had similar 
experiences of minor stressful events. However, individuals with insomnia appraise 
both daily minor and major stressful events as more stressful, compared to 
individuals with good sleep (Morin, Rodrigue & Ivers, 2003).  
In addition, another study among older adults with poor sleep and a greater amount 
of life stress had more sleep difficulties (e.g. difficulties falling asleep) but fewer 
early morning awakenings compared to those with less life stress and poor sleep 
(Friedman Brooks, Bliwise, Yesavage & Wicks, 1995). A further study found that 
highly stressful life events are associated with insomnia in individuals with chronic 
health conditions (Sutton et al., 2001).  
 
In summary, patients with chronic health conditions are more predisposed to 
psychological symptoms such as anxiety or depression that may be related to the 
symptoms of their chronic health conditions. Also, insomnia is associated with 
depression, anxiety and the nature of the relationship is complex, since psychological 
distress may cause insomnia and vice-versa in a clinical and non-clinical population. 
Also, stress is common among individuals with insomnia and is associated with 
sleep-related problems.  
 
 
2.3.3. Sleep-related Dysfunctional Beliefs  
 
More recently, cognitive factors (e.g. dysfunctional cognitions) have been shown to 
play a role in perpetuating insomnia (Morin, 1993; Morin, Stone, Trinkle, & 
Remberg, 1993) as previously stated (see section 2.1.2.), which, in turn, can elicit 
emotional arousal and cause sleep problems (Morin, et al., 1993). Since sleep-related 
dysfunctional beliefs are an important and critical factor in maintaining insomnia.  
Morin (1994) developed a reliable and valid assessment for measuring sleep-related 
cognitions: the Dysfunctional Beliefs and Attitudes about Sleep scale (DBAS), 
(DBAS-30, followed by abbreviated versions; DBAS-10; Espie, Inglis, Harvey & 
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Tessier, 2000; DBAS-16; Morin, Valliers & Ivers, 2007), which is the most widely 
used measure in assessing sleep-related dysfunctional beliefs (Carney et al., 2010).  
 
Studies have also examined whether individuals with good sleep or with insomnia 
encounter different dysfunctional beliefs and attitudes about sleep. For example, a 
cross-sectional study suggests that older individuals with insomnia (n=74) uphold 
more rigid sleep-related dysfunctional beliefs and attitudes compared to individuals 
who self-report that they have good sleep (n=71). Also, the authors suggested that an 
important clinical implication is to recognise these dysfunctional beliefs and to 
further target them for treatment (Morin, et al., 1993). Similarly, a larger cross-
sectional study (n=382) found that older adults with insomnia reported higher sleep-
related dysfunctional beliefs (as measured by DBAS-10; Espie et al., 2000) 
compared to those people who sleep well (Ellis, Hampson & Cropley, 2007).  
Furthermore, the results showed that not all dysfunctional beliefs and attitudes about 
sleep (e.g. ‘I need 8 hours sleep to feel refreshed and function well the next day’) 
were shown to differ between people with and without sleep problems and this 
pattern of dysfunctional belief was not associated with chronic insomnia.  However, 
the study used the brief version of the DBAS (e.g. DBAS-10) to assess sleep-related 
dysfunctional beliefs, which does not assess various sleep-related dysfunctional 
beliefs in the same depth as the original scales (Ellis, Hampson & Cropley, 2007). 
 
Further studies have examined the degree to which sleep disturbance is associated 
with sleep-related dysfunctional beliefs in a clinical population and suggest a similar 
association to that seen in people with primary insomnia. For example, a recent 
cross-sectional study by Carney et al. (2007) examined whether those with primary 
insomnia and those with comorbid conditions (e.g. major depressive disorder, 
fibromyalgia etc.) have similar dysfunctional beliefs about sleep in comparison to 
those without sleep complaints. The results showed that sleep-related dysfunctional 
beliefs are persistent and similar in individuals with both primary or comorbid 
insomnia. Also, the comorbid insomnia patients generated higher total scores for 
maladaptive beliefs and attitudes compared to people with primary insomnia, 
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whereas individuals without sleep complaints reported relatively low total scores of 
dysfunctional beliefs.   
Another cross-sectional study aimed to examine whether sleep disturbance in 
patients with chronic pain is associated with sleep-related dysfunctional beliefs. The 
results showed that patients with chronic pain and poor sleep (n=108) as measured 
by PSQI endorsed higher levels of sleep-related dysfunctional beliefs compared to 
chronic pain patients with good sleep quality (n=48) (Ashworth, Davidson & Espie, 
2010). Furthermore, the authors found that chronic pain patients with poor sleep 
quality and good sleep quality had similar beliefs (e.g. ‘I need 8 hours of sleep to feel 
refreshed and function well the next day’), suggesting similar results with previous 
studies in patients with primary insomnia (e.g. Ellis et al., 2007) (Ashworth et al., 
2010).  
Overall, it is clear that dysfunctional beliefs and attitudes about sleep may play a role 
in exacerbating sleep problems and perpetuating insomnia. Besides, the above 
findings showed a similar association between patients with primary insomnia and 
those with poor sleep quality and chronic health conditions (e.g. chronic pain). Also, 
the above studies showed that people with sleep problems encounter higher levels of 
dysfunctional beliefs compared to people without sleep problems.  
 
A recent comprehensive cognitive model of insomnia was proposed by Harvey 
(2002), which explains the role of cognitions in maintaining insomnia. Specifically, 
Harvey’s (2002) cognitive model proposes that negative cognitions (e.g. rumination 
or worry, such as not getting enough sleep and the effect of sleep disturbance on 
daily functioning), can trigger automatic arousal and emotional distress, which leads 
to higher levels of anxiety. As a result of these increased levels of anxiety, the 
individual becomes focused on sleep-related threats such as not getting enough sleep 
or failing to cope or function well during day. Consequently, these sleep-related 
threats trigger further worrying and distress, which leads to an increase in cognitive 
activity and arousal as well to a decrease in the likelihood of an individual sleeping. 
Furthermore, this model adds that individuals may adopt different behaviours, 
referred to as ‘safety behaviours’ (e.g. napping, drinking alcohol and avoiding 
difficult tasks) in order to lessen arousal. These ‘safety behaviours’ or maladaptive-
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sleep behaviours will be discussed in more detail in the following section. It is 
possible that reductions in the negative beliefs associated with sleep may direct a 
reduction of maladaptive sleep habits and improve sleep (Edinger, Wholgemuth, 
Radtke, Marsh & Quillian, 2001).  
Overall, Harvey’s (2002) cognitive model suggests that cognitive processes are 
responsible for dysfunctional nighttime sleep processes and reduced daytime 
functioning, through excessive worry, emotional distress and physiological arousal.  
 
In sum, the majority of the studies reviewed above were based on people with 
insomnia, suggesting that these individuals endorse higher dysfunctional beliefs 
compared to people without insomnia. One study (e.g. Ashworth et al., 2010) 
showed that patients with chronic pain and poor sleep quality reported higher levels 
of dysfunctional beliefs compared to patients with chronic pain and good sleep. 
Therefore, it is important to examine whether patients with non-clinical sleep 
disturbance and various chronic health conditions have high levels of sleep-related 
dysfunctional beliefs.    
 
 
2.3.4. Maladaptive Sleep Behaviours  
 
Behavioural theories propose that staying awake over an extensive time in the 
bedroom may result in stimulus dyscontrol, in which the bedroom environment 
might be associated with different behaviours other than sleep (Smith et al., 2005). 
This particular type of behaviour is very common among patients with chronic health 
conditions (Smith et al., 2005). For example, evidence suggests that patients with 
chronic pain spend unnecessary time in bed (e.g. to relax or nap) (Morin, Kowatch & 
Wade, 1989; Siebern, Suth & Nowakowski, 2012) or perform various daily routine 
activities in their bedroom or bed (e.g. snacking, reading and/or watching TV) 
(Morin et al., 1989). Morin et al. (1989) report that patients with chronic pain 
commonly engage in such behaviours in order to cope better with their physical 
condition, which in turn aggravates sleep disturbance. Also, a variety of other 
maladaptive behaviours such as alcohol intake as a sedative or increased caffeine 
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consumption (Smith et al., 2005) and medications are used in order to manage a 
coexisting disorder that may negatively affect sleep (Siebern et al., 2012).  
 
Similarly, many individuals who have insomnia incidences may attempt to 
recompense for reduced sleep by adopting different maladaptive behaviours such as   
a) spending excessive time in bed  (e.g. going to bed earlier and/or to getting out of 
bed later) which leads to more frequent awakenings, resulting in reduced sleep 
efficiency; and b) the practice of staying in bed while awake (i.e. the individual 
considers staying awake in bed a restful activity) which conversely leads to 
associating the bed and bedroom environment with arousal (Perlis, Giles, 
Mendelson, Bootzin, & Wyatt 1997). These two different types of maladaptive 
behaviour are interrelated and endorse one another (Perlis et al., 1997).  
 
In summary, different maladaptive behaviours (e.g. poor sleep habits) may develop 
and they can aggravate and maintain sleep problems, consistent with theories on the 
aetiology of insomnia (e.g. Spielman, 1986; Spielman, Glovinski, 1991; Morin, 
1993; Harvey, 2002). Therefore, it is essential that maladaptive behaviours of this 
kind are targeted in treatment.  
 
 
 2.4. The Impact of Sleep on Health-Related Quality of Life (HRQoL)  
 
 According to the World Health Organization (WHO, 1946), health is defined as a 
“state of complete, physical, mental and social well-being, and not merely the 
absence of disease or infirmity”.  In particular, to be considered healthy, one must 
not only be free of disease but also have a generally good quality of life. QoL is 
defined as: “an individual’s perception of their position in life in the context of the 
culture and values in which they live and in relation to their goals, expectations, 
standards and concerns” (WHO, 1998). In other words, this emphasises how 
individuals value their QoL based on their own perspective. These aspects of life are 
influenced by disease (Weaver, 2001). Consequently, the term ‘health related quality 
of life’ (HRQoL) highlights the impact of a disease or illness in relation to the 
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physical, functional and emotional or mental state and social wellbeing of an 
individual. HRQoL is an essential construct within healthcare since it measures the 
burden of disorder and it evaluates the effects of intervention on the daily 
functioning of an individual (Kyle, Morgan & Espie, 2010).  
 
There are two main types of questionnaire for measuring HRQoL in people with 
sleep disorders: generic and disease-specific (Weaver, 2001).  Generic questionnaires 
were developed to be used for a diverse population (e.g. with a wide range of 
diseases) (Weaver, 2001) whereas disease specific questionnaires were mainly 
developed for specific group of the population (Weaver, 2001).  
Advantages of generic measurements are that they allow comparisons with other 
diseases, and evaluations of different activities and roles and can be easily used on a 
diverse population (Weaver, 2001). On the other hand, generic measurements lack 
deep evaluation (Weaver, 2001) and they are not considered sensitive enough 
measures for particular treatment outcomes (Reimer & Flemons, 2003).  
 
The most commonly used generic measurements in sleep disorders are: a) the 
Medical Outcomes Study Short Forms (SF-36; Ware et al., 1992); b) the Sickness 
Impact Profile (SIP); Bergner et al., 1981); and c) the Nottingham Health Profile 
(NHP; Hunt et al., 1980) (Reimer & Flemons, 2003). In general, there is no gold 
standard generic measurement of HRQoL and sleep disorders (Reimer & Flemons, 
2003) though the SF-36 survey has been extensively used in studies examining 
health-related quality of life and insomnia (Kyle et al., 2010; Buysse et al., 2006) and 
is a recommended and an essential measurement in assessing HRQoL in individuals 
with insomnia (Buysse et al., 2006).  
 
Several studies, focusing mainly on the general/and or clinical populations, have 
examined the relationship between chronic insomnia and the impact of insomnia on 
HRQoL, showing that HRQoL is significantly reduced in people with insomnia. 
Leger, Scheuermaier, Philip, Paillard and Guilleminault (2001) found that people 
with severe insomnia scored lower on HRQoL as evaluated by the SF-36 survey, 
compared to people with mild insomnia and those with good sleep.  
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A more recent international (US, France and Japan) cross–sectional study found that 
individuals with insomnia had lower SF-36 (for both physical and mental 
components) levels across the three different countries, compared to people with 
good sleep. The authors concluded that chronic insomnia is associated with negative 
HRQoL (Leger et al., 2012). Similarly, another study found that inadequate sleep is 
associated with impairment in both physical and mental health domains (Strine & 
Chapman, 2005).  
 
When assessing clinical populations, some cross-sectional studies have analysed data 
from an observational study (Medical Outcomes Study [MOS] to examine the 
relationship between insomnia and HRQoL in patients with various chronic health 
conditions. For example, Katz and Horney (2002) found that insomnia is 
independently associated with poor HRQoL (e.g. after controlling for confounding 
variables such as anxiety, depression and medical comorbidities) in patients with 
various chronic health conditions (e.g. hypertension, myocardial infarction, diabetes, 
congestive heart failure and clinical depression). Furthermore, consistent with Leger 
et al. (2001) the authors found that a higher severity of insomnia signifies worse 
HRQoL.  
 
A further line of evidence is aimed primarily at examining the association between 
poor sleep quality as measured by the PSQI and HRQoL (SF-36) in patients with 
various chronic health conditions. In this respect, Fortner et al. (2002) found that 
breast cancer patients with poor sleep quality had impaired HRQoL, mainly 
manifested in their ability to perform work and daily tasks, and they also reported 
low energy levels for daily activities. A more recent study found that patients with 
multiple sclerosis (MS) and poor sleep quality had a lower mental and health status 
as measured by the SF-36 survey when compared with good sleepers.  
Poor sleep quality was found to be an independent predictor of HRQoL in patients 
with MS (Merlino et al., 2009). These findings suggests that poor sleep quality is 
associated with impaired HRQoL.  
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Finally, Manocchia, Keller and Ware (2001) examined whether sleep problems in 
patients with various chronic conditions (e.g. clinical depression, diabetes, 
congestive heart failure, arthritis, myocardial infarction, arthritis, back problems, 
etc.) are related to reductions in HRQoL. The authors found that individuals with 
different levels (mild, moderate and severe) of sleep-related problems had reductions 
in HRQoL compared to those with chronic health conditions without sleep problems. 
Furthermore, the results showed that severe sleep problems are associated with 
reductions in both work quality and productivity and with a higher use of mental and 
physical healthcare services (Manocchia et al., 2001).  
Thus, insomnia presents a significant economic burden for both the individual and 
society (Mack & Rybarzyck, 2011) and it is also associated with increased healthcare 
utilisation in different countries (Leger, Guilleminault, Bader, Levy, & Paillard, 
2002; Novak, Musci, Shapiro, Rethelyi, & Kopp, 2004; Simon & VonKorf, 1997; 
Daley, Morin, LeBlanc, Gregoire & Savard, 2009).  
 
Overall these findings suggest that sleep problems, including insomnia and poor 
sleep quality, are associated with a negative impact in all domains of HRQoL as 
evaluated by the SF-36 survey among both the clinical and non-clinical population, 
as well as with increased related costs for the individual and society. Therefore, it is 
clear that early and effective treatment for sleep-related problems may prove 
beneficial for both society and individuals with such problems. Kyle et al. (2010) 
encourage future studies comprising of generic measurements of HRQoL or other 
equally valid measurements related to insomnia.  
 
The reviewed literature shows conclusively that sleep-related problems are 
associated with psychological distress, higher dysfunctional sleep-related cognitions 
and significant impairment in HRQoL. Morin (2003) concluded that since insomnia 
is associated with significant detrimental health effects, an effective treatment for 
insomnia should not only aim to improve sleep but should also lead to clinical 
improvements, including better daytime functioning, reduced fatigue and improved 
mood, as well as quality of life. However, the current research tends to focus on 
insomnia rather than on non-clinical sleep disturbance.  
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Given the magnitude and complexity of the relationship between various factors and 
insomnia, it is possible that a similar relationship may exist in patients with non-
clinical sleep disturbance.  
Therefore, one of the aims of the current study is to explore if these factors are also 
pertinent in patients with chronic health conditions and non-clinical sleep 
disturbance. Nevertheless, gaining a greater understanding of the possible aetiology 
of factors potentially contributing to non-clinical sleep disturbance in populations 
with chronic health conditions does not provide useful information unless it can be 
used to derive meaningful interventions or treatments that could ultimately improve 
the psychological adjustment and health-related quality of life of these patients. 
Consequently, another aim of the current study is to investigate whether an 
intervention based on targeting the modification of some psychological factors could 
produce positive results that would bring about a meaningful and positive change in 
patients with chronic health conditions and with self-reported non-clinical sleep 
disturbance. Similar studies in the related field, in particular of patients with 
insomnia, have shown the effectiveness of treatment in sleep parameters and other 
clinically important outcomes. Evidence for the efficacy of this improvement will be 
reviewed in the subsequent sections. In general, there is a vast body of literature that 
suggests that the lives of individuals with insomnia and chronic health conditions can 
be improved by different types of treatments.  
 
 
2.5. MANAGEMENT OF SLEEP PROBLEMS   
 
2.5.1. Treatments  
 
At first, the management of insomnia among patients with chronic health conditions 
aims to treat the primary condition (Kamel & Gammack, 2006; McCrae & Lichstein, 
2001b) and comorbid insomnia is treated when the symptoms are severe or when the 
treatment for the primary condition is ineffective (McCrae & Lichstein, 2001b). 
Currently, there are various treatments available which aim to effectively manage 
insomnia as a comorbid condition. They include various types of pharmacological 
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treatments, complementary and alternative therapies (e.g. natural remedies and 
dietary supplements) and behavioural and psychological therapies (Kamel & 
Gammack, 2006).  
The following section will provide a brief overview of the various treatments 
available and their effectiveness in managing sleep-related problems. Particular 
attention is given to the effectiveness of behavioural and psychological therapies and, 
more particularly, to Cognitive Behavioural Therapy (CBT) since it was the 
treatment implemented in the current study and it combines both psychological and 
behavioural therapies.  
 
 
2.5.2. Pharmacological and complementary and alternative therapies 
 
Pharmacological treatments are mainly used for treating patients with insomnia 
(Currie, 2007; Morin, 2004; Koffel, Koffel & Gehrman, 2015) and other sleep-
related problems (Currie, 2007) since they are widely available and provide rapid 
improvement (Mitchell, Gehrman, Perlis & Umscheid, 2012).  
Meta-analyses have shown that pharmacological treatments are effective in 
managing insomnia in the short term (Nowell et al., 1997; Buscemi et al., 2007; 
Smith et al., 2002), and their use is associated with several adverse effects such as 
cognitive impairment, drowsiness headaches and dizziness (Holbrook, Crowther, 
Lotter, Cheng, & King, 2000; Buscemi et al., 2007).  
Various natural remedies and dietary supplements are also promoted as sleep aids 
such as valerian that is most commonly used herbal remedy (Taibi, Landis, Petry & 
Vitielo, 2007) and dietary supplements such as melatonin hormone and alcohol with 
limited evidence around effectiveness (NIH, 2005). Several systematic reviews and 
meta-analyses have evaluated the effectiveness of valerian for sleep-related problems 
(e.g. Bent, Padula, Moore, Patterson & Mehling, 2006; Stevinson & Ernst, 2000; 
Taibi et al., 2007; Fernandez-San-Martin et al., 2010). However, the evidence is 
mixed and/or inconclusive with regard to its effectiveness for alleviating sleep-
related problems. Similarly, a recent meta-analysis found that there is insufficient 
evidence to support the efficacy of other herbal remedies (Leach & Page, 2015). The 
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results show that further studies are essential, with more vigorous and robust 
methodological qualities to examine valerian as well as other herbal remedies and 
their relation to sleep-related problems.  
In summary, since there is limited evidence of the effectiveness of herbal remedies 
and dietary supplements in managing sleep problems, it is unwise to consider them 
as effective treatments.  
 
2.5.3. Behavioural and Psychological Treatments  
Another type of treatment used in the management of sleep-related problems 
includes behavioural and psychological therapies. Although pharmacological 
treatment is the most common method for treating insomnia, the positive effects have 
been shown to be effective only in the short term, and their use is frequently 
associated with a number of side effects as previously discussed. Hence, since 
insomnia emerges from a complex interaction of physiological, cognitive and 
behavioural factors (Spielman, 1986; Spielman & Glovinski 1991; Morin, 1993), 
evidence shows that it can be managed within behavioural or psychological 
therapies, which aim to change both the perpetuating and potential precipitating 
factors that contribute to insomnia (Morin, 2006), and explicitly to the aetiology of 
insomnia. These therapies are considered beneficial without any risk of intolerance 
or adverse effects (Trauer et al., 2015).  
A growing body of evidence suggests that these treatments are effective in improving 
sleep patterns in patients with primary insomnia (Morin et al., 1999; Morin, Culpert, 
Shwartz, 1994; Murtagh & Greenwood, 1995). For example, Morin et al. (1999) 
found that 70%-80% of patients treated with behavioural or psychological therapies 
showed improvement in sleep. Furthermore, evidence suggests that behavioural 
treatments are more effective than pharmacological treatments. Morin, Colecchi, 
Stone, Sood and Brink (1999) found that cognitive-behavioural therapies led to 
longer-term improvements than pharmacological treatments in patients with primary 
insomnia. Also, a meta-analysis found that both pharmacological and behavioural 
treatments are effective, with behavioural treatment being more effective at reducing 
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sleep latency (Smith et al., 2002). Recent evidence also suggests that patients who 
use medication show a higher preference for non-pharmacological treatment to treat 
their sleep problems (Omvik, Pallesen, Bjorvatn, Sivertsen & Havik, 2010). 
Since non-pharmacological treatments are gaining increasing attention and have been 
shown to be as effective as pharmacotherapy, and more effective in the long-term, 
this chapter aims to introduce the most commonly used non-pharmacological 
therapies for the management of insomnia.  
 
Initially, in the 1970s and 1980s, insomnia was commonly treated by stimulus 
control therapy (SCT: Bootzin, 1972; Bootzin, Epstein & Wood, 1991), paradoxical 
intention and relaxation-based therapies (RT) (Bootzin & Ebstein, 2011). Later other 
behavioural therapies for insomnia were introduced such as the sleep restriction 
therapy (SRT: Spielman, Saskin & Thorpy, 1987; Glovinski & Spielman, 1991). 
Further treatments were developed such as educational sleep hygiene (SH: Hauri, 
1991) and cognitive therapy (Morin, 1993), and more recently a hybrid approach was 
developed, most commonly known as cognitive-behavioural therapy (CBT) (Morin, 
1993), the approach endorsed in the current study. Each of these therapies is roots in 
different theoretical perspectives (behavioural, educational or cognitive) that target 
different aspects of insomnia and are shown to be effective, either as single-treatment 
methods or in combination with various other techniques. The subsequent section 
provides an overview of the different therapies for the management of insomnia.       
It contains a brief description of their theoretical backgrounds, along with the 
supporting scientific evidence, with a view to providing a comprehensive 
justification for the selection of CBT-I and for the decision to administer CBT-I in 
the form of a self-help booklet in the current study.  
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2.6. Behavioural Therapies for Insomnia  
 
2.6.1. Theoretical background of Behavioural Therapies  
 
Behavioural therapies for the management of insomnia include: Stimulus Control 
Therapy (SCT: Bootzin, 1972; Bootzin et al, 1991), Sleep Restriction Therapy (SRT: 
Spielman et al., 1987; Glovinski & Spielman, 1991), Sleep Hygiene Therapy (SHT: 
Hauri, 1991) and relaxation-based treatments (e.g. imagery relaxation) (Morin, et al., 
2006), which additionally target some cognitions (e.g. cognitive arousal) (Morin, 
2004).  
 
SCT (Bootzin, 1972; Bootzin, et al., 1991) is theoretically underpinned by learning 
theory (Ebben & Spielman, 2009) and is grounded in the principle that certain sleep 
disturbances are behaviourally habituated (Martin et al., 2000). For example, in SCT, 
individuals learn to re-associate or improve the association between sleep and 
stimulus conditions (e.g. bed, bedtime and bedroom) (Morin, 1993). Individuals are 
directed to restrict all other behaviours/activities that occur in the bedroom, other 
than sleep and sex, only retiring when they are sleepy. If they find themselves unable 
to sleep after 15 or 20 minutes they must leave the bedroom until they are 
sufficiently sleepy. Also SCT demands that individuals establish a pre-sleep routine 
every night and refrain from napping during the day (Currie, 2007; Trauer et al., 
2015). SCT might be more suitable for patients with a counter-productive and 
inconsistent sleep schedule (Edinger & Whohlgemuth, 1999).  
SRT (Spielman et al., 1987; Glovinski & Spielman, 1991) is a different behavioural 
therapy, and its rationale is that an extensive time spent in bed perpetuates insomnia. 
Consequently, as the name implies, it demands that the individual stay in bed only 
when sleeping and leave the bed when awake (Spielman Saskin & Thorpy, 1987). 
For example, if an individual with insomnia sleeps for only 5 hours out of 8, it is 
recommended that the time in bed to be reduced to 5 hours, referred to as the ‘sleep 
window’ which can be adjusted weekly until optimal sleep efficiency is achieved 
(Morin, 2004).  In order to achieve the targets of SRT, sleep efficiency is computed 
by dividing total sleep time by the total time in bed multiplied by 100. The target for 
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an individual with insomnia would normally be 85% (Morin, 2004). If an 
individual’s sleep efficiency is below 80% the therapy recommends reducing the 
sleep window by 15-20 minutes. In cases where, sleep efficiency is above 90% the 
sleep window can be increased by the same amount (Morin, 2004). Consequently, 
SRT aims to reduce sleep deprivation, which endorses quicker sleep-onset, better 
sleep efficiency with fewer incidences of waking during the night (Morin et al., 
1999; Morin, 2004).  
Both SCT and SRT aim to reduce the behavioural factors that prolong or maintain 
insomnia (Stepanski & Perlis, 2000).  
 
SHT (Hauri, 1991) is an educational-behavioural oriented therapy that targets 
lifestyle habits and environmental factors that inhibit sleep (Edinger & Means, 
2005). Specifically, SHT educates individuals about healthy sleep behaviours (e.g. 
that they should exercise regularly, limit nicotine, caffeine, and, alcohol consumption 
and eat light meals before bedtime), sleep-promoting environmental conditions (e.g. 
room temperature, limited noise, a dark room and a comfortable sleep environment) 
(Edinger & Means, 2005; Stepanski & Wyatt, 2003).  
 
Relaxation-based treatments are considered alternative behavioural therapies for 
insomnia. These techniques are based on the theory that individuals with insomnia 
usually experience high levels of physiological and/or cognitive arousal during the 
day and at night (Morin et al., 1999) and they can be applied to individuals who are 
relatively anxious about not being able to sleep (Edinger & Wholgemuth, 1999).  
For example, progressive muscle relaxation (PMR), autogenic and biofeedback 
relaxation techniques aim to reduce physical arousal or muscle tension, while other 
relaxation techniques such as imagery training, meditation and thought stopping are 
mainly focused on eliminating cognitive arousal (Morin, 2004).  
Before deciding on the optimal intervention, it is best to consider the effectiveness of 
the interventions. The following section reviews the effectiveness of behavioural 
therapies either as single therapies or in combination in patients with primary 
insomnia or comorbid insomnia.  
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2.6.2. Effectiveness of Behavioural Therapies  
 
Evidence suggests that behavioural-based therapies like SCT and SRT are effective 
as single-therapies for patients with primary insomnia. For example, meta-analysis 
data and reviews suggest that SCT is empirically supported as an effective single 
therapy (e.g. Morin et al., 1994; Morin et al., 1999) and can be considered as a 
recommended treatment for insomnia (Morgenthaler et al., 2006).  
Also other studies have examined the effectiveness of SRT and showed that SRT is 
an effective treatment for sleep problems (Spielman et al., 1987; Friedman, Bliwise, 
Yesavage & Salom, 1991). Similarly, meta-analysis data found that SRT is an 
effective single therapy (e.g. Morin et al., 1994). Furthermore, in accordance with the 
Practice Parameters of the Standards of Practice Committee, SRT can be 
recommended as a single therapy (Morgenthaler et al., 2006).  
On the other hand, some evidence suggests that SHT is not effective as a single 
intervention (Morin et al., 1994) and is not recommended as a single therapy for 
insomnia (Morgenthaler et al., 2006) because there is limited evidence.  
However, sleep hygiene is considered an essential part of treating insomnia by 
promoting healthier sleep hygiene practices (Morin, 1993).  Since environmental and 
lifestyle factors may influence sleep disturbance (Morin, 1993; Morin, 2004), poor 
sleep hygiene may be perceived as a perpetuating factor (Stepanski & Wyatt, 2003).   
 
Also, further development of these approaches allow for combined behavioural 
interventions.   
Single-case studies indicate the effectiveness of combined behavioural interventions 
in patients with chronic health conditions and sleep problems. For example, three 
single case studies included a patient with haemophilia disorder (e.g. Varni, 1980), 
cancer (e.g. Stam & Bultz, 1986) and depression (Morin, Kowatch & O’Shanick 
(1990). Specifically, Varni (1980) examined the effectiveness of a behavioural 
intervention, which was an amalgam of various techniques such as PMR, meditative 
breathing, cognitive refocusing and stimulus control, and found that this combination 
of techniques was related to a significant increase of hours per night with continuous 
sleep. Stam & Bultz (1986) found that a behavioural intervention, based on 
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progressive muscle relaxation and imagery training significantly improved total sleep 
time for up to 12-months and decreased sleep latency. Finally, Morin et al. (1990) 
found that SRT was effective in increasing total sleep time in a depressed patient and 
these improvements were maintained at a 4-month follow-up.  
In addition, Morin, et al. (1989) conducted a small sample size (n=3) study to 
examine the efficacy of a behavioural combination treatment consisting of SCT and 
SRT for patients with chronic pain using a multiple baseline design.  Each participant 
showed significant improvements in both subjective and objective measures of sleep 
patterns at post-treatment and follow-up.  
 
The first randomised behavioural study was conducted by Cannici, Malcom and Peek 
(1983) and it showed that muscle relaxation was effective in improving sleep latency 
and the total sleep time in cancer patients.  
A more recent study randomized older adults with comorbid medical (mainly chronic 
pain) or psychiatric disorders (e.g. depression) to a treatment intervention, consisting 
of four sessions of sleep hygiene instructions, relaxation and an SCT group or a 
control group. The results showed significant subjective sleep improvements as 
measured by sleep diary (e.g. time awake after sleep onset, sleep efficiency and sleep 
quality) at post-treatment and at a 3-month follow-up. However, no significant 
differences were found for anxiety and depression outcomes (Lichstein, Wilson & 
Johnson, 2000). 
Overall, the above evidence shows that behavioural therapies are promising and 
effective for treating insomnia in both non-clinical and clinical populations as single 
therapies or when used in combination. However, studies within a clinical population 
(including patients with chronic health conditions such as cancer, pain, haemophilia 
etc.) have some important pitfalls in their designs with small sample sizes, and other 
issues that limit the generalisability of the findings.  
As discussed previously, evidence shows that sleep problems are perpetuated due to 
the influence of various behavioural and cognitive factors. Consequently, it can be 
argued that the above therapies are inadequate, since they fail to take into account – 
and/or they do not directly address – all the perpetuating factors (e.g. dysfunctional 
beliefs) that affect sleep (Edinger & Means, 2005).  
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Even though some relaxation therapies include some cognitive relaxation methods, 
as discussed above, they are predominantly, relaxation-based therapies, which aim to 
reduce continued arousal and sleep-related anxiety by not targeting cognitive factors 
that maintain sleep problems (Edinger & Means, 2005).  
 
 
2.6.3. Cognitive Behavioural Therapy for Insomnia (CBT-I) 
 
So far, a variety of treatments have been discussed, such as pharmacological, 
complementary/alternative (e.g. herbal remedies), together with a variety of 
behavioural therapies (e.g. stimulus control, sleep restriction, relaxation therapies 
and sleep-educational hygiene). Pharmacological therapies are associated with side 
effects and shown to be effective in short-term; on the other hand, complementary 
therapies are limited evidence-based and behavioural therapies shown to be effective 
but they do not directly target all that factors that maintain sleep problems.  
Therefore, in order to overcome the limitations of behavioural therapies, and by 
taking into account the aetiology of insomnia (see section 2.1.2.). Morin (1993) 
proposed cognitive therapy that encourages patients to re-evaluate their thoughts 
concerning insomnia, and to understand of its causes and consequences.  
 
Particularly, the main aim of cognitive therapy is to give patients a more realistic 
perspective on their sleep related behaviours by using the cognitive restructuring 
techniques of reappraisal, reattribution and decatastrophizing (Morin, 1993).          
For example, individuals are instructed to identify cognitions related to dysfunctional 
beliefs, challenging their validity and replacing sleep-related dysfunctional 
cognitions with more adaptive and reasonable ones altering interpretations of sleep 
and sleep related behaviours (Morin, 1993). Subsequently, cognitive restructuring 
techniques were included in the behavioural methods to form a more comprehensive 
treatment approach to insomnia, known as Cognitive Behavioural Therapy for 
insomnia (CBT-I) (Morin, 1993; Morin, 2004). The main aim of CBT is to target 
those factors that perpetuate insomnia (Morin, 1993; Morin, et al., 1994; Siebern et 
al., 2012).   
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Specifically, CBT-I aims to change maladaptive sleep habits and dysfunctional 
beliefs and attitudes about sleep that may trigger and support anxiety, and to educate 
individuals about healthier sleep habits and lifestyle practices (Morin, 1993). A 
typical CBT-I protocol integrates three distinct key components: a) behavioural (e.g. 
combining SCT and SRT), b) cognitive (e.g. cognitive restructuring techniques) and 
c) educational (e.g. SH) as outlined and discussed above, together with an optional 
medication-withdrawal component for individuals who rely on sleep medication 
(Morin, 1993).  With regards to medication-withdrawal, the aim is to help the 
individual to gradually withdraw from sleep medication (Morin, 1993). In addition, 
to these components, relaxation-based therapies have been assimilated into the 
package of CBT-I (Morin, 2004; Bootzin & Epstein, 2011). Consequently, 
incorporating various methods is valuable and can enhance the outcome (Morin, et 
al., 1999; Morin, 2006) since any single technique may partially address the sleep 
problem as a whole (Lacks & Morin, 1992). Also a more recent systematic review 
(which included randomized controlled studies) showed that CBT is more effective 
than any single component (e.g. stimulus control, relaxation-training, etc.) (Wang, 
Wang & Tsai, 2005).  
 
CBT is usually delivered in the form of face-to-face sessions, either individually or 
in the form of a group (Pigeon, 2010b) in weekly sessions that continue over a 6 to 8-
week period (Pigeon, 2010b). Initially, CBT was a treatment for patients with 
primary insomnia (Rybarczyck et al., 2005) and to date it has been systematically 
assessed in a healthy population with insomnia. The National Institute of Health 
(2005) concluded that CBT is at least as effective as medication for the short-term 
treatment of insomnia, and its beneficial effects may last longer than pharmaceutical 
solutions, extending beyond the end of the period of active treatment. Consequently, 
CBT is currently the best treatment for insomnia (Espie, 1999; Espie, 2009; NIH, 
2005; Mack & Rybarczyck, 2011).  
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Whereas, until recently, studies in the current area used to exclude individuals with 
comorbid insomnia, and as previously discussed (see section 2.5.1.) the initial 
approach to managing insomnia was to treat the primary condition, since initially it 
was believed that medical or psychiatric illness were the main cause of insomnia 
among chronically ill patients with insomnia. However, the evidence considered 
above suggests that these factors were not necessarily the main cause of insomnia 
among individuals with chronic health conditions and sleep problems. The reviewed 
evidence suggests that other factors, such as psychological, are shown to be 
associated with insomnia and the evidence also suggests that patients with comorbid 
insomnia may develop several maladaptive behaviours (both cognitive and 
behavioural) that contribute to insomnia (Stepanski & Rybarczyck, 2006). In 
addition, earlier behavioural studies (e.g. Varni, 1980; Stam & Bultz, 1986; Morin et 
al., 1990) despite their limitations as stated previously (see section 2.6.2) showed that 
behavioural therapies could be considered beneficial for the treatment of comorbid 
insomnia.  
 
Therefore, taking into account the cognitive and behavioural factors that play a role 
in the development and maintenance of comorbid insomnia and by following the 
promising evidence regarding the effectiveness of CBT-I in a healthy population, 
more recent, studies have examined the effectiveness of CBT–I in patients with 
comorbid insomnia. Exciting evidence has shown the effectiveness of behavioural 
and cognitive therapies for patients with chronic health conditions and sleep 
problems (e.g. Smith et al., 2005; Morin, et al., 2006; Stepanski & Rybarczyck 2006; 
Geiger-Brown et al., 2015). The section below provides a review of studies 
examining the effectiveness of CBT-I for patients with various chronic health 
conditions and sleep problems.  
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2.6.3.1. Effectiveness of Multicomponent CBT-I for patients with 
Chronic Health Conditions  
Currie, Wilson, Pontefract and deLaplante (2000) conducted the first CBT-I study on 
patients with chronic pain and insomnia. The supported hypothesis of the 
intervention was that behavioural factors play a role in exacerbating or maintaining 
sleep problems in patients with chronic painful conditions. Consequently, altering 
these maladaptive behaviours can promote sleep improvements, despite the fact that 
pain is not targeted (Currie et al., 2000). Patients were randomly assigned to either 
the CBT 7-week group intervention or to the waiting-list (WL) group. The results 
showed that the CBT-I 7-week group reported significant improvements in several 
sleep parameters (e.g. sleep quality, sleep onset latency, sleep efficiency and wake 
time after sleep onset) as measured by self-report measures (e.g. sleep diary and 
PSQI) and also showed less motor activity as measured by an objective measure (e.g. 
actigraphy). Also these sleep improvements were maintained at the 3-month follow-
up assessment. However, no significant reductions were found in depression 
following the completion of the intervention.  Overall, this study showed that group 
CBT-I is effective in improving sleep in patients with chronic pain but not in 
reducing emotional distress (e.g. depression).  
 
A later study was conducted by Edinger, Wohlgemuth, Krystal & Rice (2005) in 
patients with fibromyalgia who either received 6-weekly CBT-I individual sessions, 
sleep hygiene, or treatment as usual care control (UCC). The results showed that 
participants in the CBT-I group showed a greater improvement (50%) in their 
nocturnal wake time than the SH (20%), and UCC (3.5%) groups, as measured by 
sleep logs. Also the CBT-I group showed reduced insomnia severity symptoms and 
improved mental well-being and mood compared to the UCC group. The SH group 
showed positive outcomes in pain and well-being. In other words, the current 
findings may be interpreted as an indication that the CBT-I intervention has a greater 
effect in improving sleep as well a greater effect in changing other clinical outcomes 
related to sleep (e.g. mood).  
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In another randomized trial, patients with non-malignant pain were randomized to 
either an 8-week individual CBT-I group or to a control group. CBT-I was effective 
in improving sleep (as measured by sleep diary and ISI), whereas no differences 
were found in terms of mood measures (e.g. depression as measured by BDI) 
between the two groups (Jungquist et al., 2010).  
 
Further study found support for the efficacy of CBT-I (e.g. tailored for cancer 
patients) in patients with cancer, concluding that the implementation of CBT-I 
improved subjective sleep indices, reduced levels of depression and anxiety, and 
improved global quality of life (disease-specific questionnaire) (Savard, Simard, 
Ivers & Morin, 2005).  Similarly, Qunsnel, Savard, Simard, Ivers, and Morin (2003) 
found that CBT-I was effective in improving sleep in women with non-metastatic 
breast cancer. The results also showed a reduction in depressive symptoms, physical 
fatigue and improved quality of life (e.g. global and cognitive dimensions) as 
measured by an HRQoL disease-specific questionnaire. However, no significant 
differences were found in anxiety.  
 
Another study randomized patients with chronic obstructive pulmonary disease 
(COPD) either to a 6-week CBT-I intervention or to a 6-week wellness education 
(WE) (e.g. including education on how the lungs work, medications, breathing 
techniques, etc.). The CBT-I group showed significant improvement in insomnia 
severity, global sleep quality, wake after sleep onset, sleep efficiency, sleep-related 
dysfunctional beliefs and fatigue, whereas the WE groups showed reduced levels of 
anxiety and depression (assessed using tension anxiety and depression-dejection). 
These findings indicate that CBT-I is an effective treatment in improving overall 
sleep quality and other sleep-related outcomes (Kapella et al. 2011).   
Additional studies have examined the effectiveness of CBT-I in patients with mixed 
chronic health conditions. Rybarczyk, Lopez, Benson, Alsten, and Stepanski (2002) 
assigned older adults with chronic health conditions (e.g. coronary artery disease, 
osteoarthritis and type II diabetes) either to classroom CBT-I including relaxation 
techniques, to home–based video audio relaxation treatment (HART) or to delayed 
control. The CBT group experienced significant improvements in subjective sleep 
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patterns (sleep diary) and a reduction in sleep-related dysfunctional beliefs. Also, 
sleep improvements were maintained at a 4-month follow-up. Similarly, the HART 
group showed sleep improvements, but the CBT group showed greater 
improvements. Sleep improvements were not related to improved health-related 
quality of life, pain and anxiety.  
In a later study, Rybarczyck et al. (2005) included a different group of older adults 
(55 years and older) with osteoarthritis, coronary artery disease or pulmonary 
disease, and participants were randomly assigned to either 8 weekly 2-hour CBT-I 
classroom sessions or stress management and wellness training (SMW). The CBT 
group showed significant sleep improvement and reductions in sleep-related 
dysfunctional beliefs compared to the SMW group. However, no significant 
differences were found for mood, pain and health-related quality of life.  
 
Overall, based on the evidence emerging from the above studies, we may conclude 
that CBT-I is an effective treatment for comorbid insomnia associated with various 
chronic health conditions.  However, despite its effectiveness, CBT-I is an expensive 
treatment option and is not easily accessible as it is only available through face-to-
face sessions with a specialist (Espie, 2009; Perlis & Smith, 2008). Other barriers in 
terms of CBT implementation include time and a lack of CBT-trained therapists 
(Morin & Benca, 2012; Perlis & Smith, 2008; Edinger, 2009). Due to these barriers, 
only few a patients with insomnia receive CBT to manage their problems (Espie, 
2009). In terms of its cost-effectiveness, CBT-I group therapy is a cost effective 
method compared to individual therapy for the management of insomnia (Bastein, 
Morin, Quellet, Blais & Bouchard, 2004). However, this mode of treatment still 
shares constraints, as with individual therapy, in terms of practical issues such as 
geographical restraints and transport costs (Bastein et al., 2004).  
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2.7. Stepped Care Model: Self-help CBT-I  
 
Recently Espie (2009) proposed a 5-level stepped care model: ‘a health technology 
solution for delivering CBT as the first line of insomnia treatment’ to increase 
resources and improve clinical care for individuals with insomnia. The five levels of 
this model differ in the way they provide CBT-I and cost, although the treatment 
shares the same context. For example, individuals initially begin with less restrictive 
treatment (e.g. CBT is provided in the form of self-help) and thereafter individuals 
may progress to more intensive treatment (e.g. group CBT delivered by a trained 
therapist; then followed by a graduate psychologist, followed by a clinical 
psychologist and finally by an expert at a behavioural medicine clinic).  
Espie (2009) recommends self-help (SH) CBT-I as the initial treatment step of the 5-
level stepped care model, since it is the least restrictive evidence-based treatment to 
generate meaningful health benefit, it can be easily administered, it is cost-effective 
and can provide value to a significant proportion of patients while not causing any 
adverse risk effects.  
 
Self-help (SH) treatments are described as standardized psychological treatments that 
patients can self-administer in their own time and at their own pace (van Straten  & 
Cuijpers, 2009) and can be applied through various media such as a booklets 
(bibliotherapy), CD/ROM, the Internet or the media (Espie, 2009; van Straten & 
Cuijpers, 2009). Compelling evidence from meta-analysis data suggests that SH 
treatments based on behavioural therapies and CBT are effective as face-to-face 
treatments but with small to moderate effects, which means that SH treatments 
cannot take the place of therapist–led CBT interventions (van Straten & Cuijpers, 
2009) but may be considered effective enough to be integrated into stepped care at 
the initial entry level (van Straten & Cuijpers, 2009; Ho et al., 2015).  
The following section reviews the effectiveness of CBT-I in the form of self-help for 
patients with insomnia and comorbid insomnia.   
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2.7.1. Effectiveness of CBT-I in the form of Self-Help (SH)  
 
Early studies have established the effectiveness of the CBT-I SH booklet for patients 
with primary insomnia. Mimeault and Morin (1999) examined the efficacy of a 
CBT-I SH booklet with and without professional guidance in adults (n=54) with 
primary insomnia. Participants were randomly assigned either to the CBT-I SH 
booklet with or without professional guidance, or to the waiting list (WL) group. At 
post treatment, both CBT-I SH groups showed significantly improved sleep, reduced 
anxiety, depressive symptoms and sleep-related cognitions compared to the WL 
group and these improvements were maintained over three-months. In addition, at 
the end of the intervention the CBT-I group with minimal professional guidance 
showed greater improvements in sleep outcomes, though these improvements 
disappeared at the 3-month follow-up. The current study suggests that CBT-I in the 
form of a SH booklet with minimal professional guidance (or indeed with none) is an 
effective approach for patients with primary insomnia.  
 
Another study showed that CBT-I in the form of self-help does not lead to significant 
sleep improvements (as measured by sleep diary). On the other hand, the results 
showed that CBT-I self-help is effective in reducing sleep-related dysfunctional 
beliefs, depressive symptoms and HRQoL (e.g. mental component). In sum, the 
authors suggested that CBT-I self-help benefits individuals in coping with insomnia  
(van Straten, Cuijpers, Smit, Spermon, & Verbeek, 2009). Further study based on 
community sample (without screening or excluding any participants with medical or 
psychiatric comorbidities) found that the CBT-I intervention which included six self-
help booklets provided by mail every week (with an optional free phone line for 
further support), was effective in improving subjective sleep quality and reducing 
symptoms of insomnia severity, anxiety and depression. Subjective sleep 
improvements were maintained at a 6-month follow-up, whereas improved levels of 
anxiety and depression at follow-up disappeared (Morin, Beaulieu-Bonneau, 
LeBlanc & Savard, 2005). CBT-I in the form of self-help is effective in improving 
sleep any psychological distress among diverse group of participants.   
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Few studies have examined the effects of the CBT–I SH booklets for patients with 
comorbid insomnia in patients with mixed chronic health conditions. For example, a 
recent study in the UK by Morgan, Gregory, Tomeny, David, & Gascoigne (2012) 
examined the effectiveness of a 6-week CBT-I SH booklet with access to telephone 
support (from expert patients) in older adults (≥ 55 years old) in primary care 
reporting insomnia symptoms associated with chronic health conditions (e.g. cancer, 
osteoarthritis, diabetes mellitus, chronic obstructive disease, fibromyalgia, coronary 
heart disease and hypertension, depression and Parkinson’s disease). Participants 
showed significant improvements in sleep quality and reduced symptoms of 
insomnia and these improvements were maintained in the long term. However no 
significant differences were found in daytime fatigue severity.  
 
Another study by Rybarczyk, Mack, Harris and Stepanski (2011) aimed to compare 
two different methods of CBT–I SH (e.g. CBT-I SH booklet vs. CBT-I multimedia 
version) based on the same content with weekly telephone support in older adults 
(aged 55 and older) (n=106) with osteoarthritis (n=33), coronary disease (n=33) or 
no significant medical conditions (n=40). Findings showed that CBT-I SH 
interventions were effective in improving sleep measures and dysfunctional beliefs 
and attitudes about sleep at post treatment. At one-year follow-up (n=86), the results 
showed that sleep improvements were sustained, showing effectiveness in the long 
term. The authors concluded that CBT-I SH with minimal support has the potential 
to be equally effective as individual treatment and is cost-effective for patients with 
insomnia and comorbid insomnia.  
 
Jermelov, Lekander and Blom (2012) compared the effects of a 6-week CBT-I 
booklet with or without therapist support to a waiting list control (WLC) in patients 
with comorbid insomnia. Both CBT-I groups showed improved sleep quality and 
reduced insomnia severity symptoms compared to the WLC. The CBT–I group with 
telephone support also showed reduced dysfunctional beliefs about sleep, perceived 
stress, daytime fatigue and reduced sleep-related behaviours when compared to the 
WLC. This study also showed that improved sleep changes were higher in the group 
with telephone therapist support at post-treatment and at a 3-month follow-up. 
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Overall, these results suggest that CBT-I with therapist support leads to greater sleep 
improvements and improve coping with insomnia.  
 
A recent study (Casault, Savard, Ivers & Savard, 2015) examined the effectiveness 
of a minimal 6-week CBT-I SH booklet accompanied by a brief telephone 
consultation on patients with cancer and acute insomnia (e.g. insomnia less than 6 
months). The minimal multimodal CBT-I SH booklet appeared to improve sleep 
parameters, reduced anxiety and depression and significantly reduced maladaptive 
sleep habits and dysfunctional beliefs and attitudes about sleep and improved 
subjective cognitive functioning of the QoL. Also, the current study shows that these 
therapeutic improvements were maintained for six months. However, no significant 
differences were found for fatigue or global quality of life.  
 
Finally, Rybarczyck, Lopez, Schelble and Stepanski (2005) examined the 
effectiveness of a different method of delivery of CBT–I SH in older patients with 
comorbid insomnia, a home CBT-I based video with weekly telephone support. The 
study sample was older adults with comorbid medical conditions (e.g. hypertension, 
coronary artery disease, osteoarthritis, type II diabetes, myocardial infarction etc.). 
The results showed that participants, compared to controls, showed significant 
improvement in self-reported overall sleep quality, dysfunctional beliefs and 
attitudes about sleep, mood, and HRQoL (e.g. daytime and social functioning and 
energy vitality). The current study suggests that home-based video is a relatively 
beneficial and cost-effective treatment.  
 
In conclusion, CBT–I SH for patients with chronic health conditions and insomnia 
seems encouraging, since compelling evidence shows it to be effective in alleviating 
sleep, with some evidence suggesting that CBT-I is effective in reducing 
psychological distress (e.g. anxiety, depression and stress), dysfunctional beliefs and 
maladaptive sleep habits and improved HRQoL. Furthermore, evidence suggests that 
CBT-I SH as an initial treatment step of the stepped care model is considered an 
advantageous approach as a starting treatment since it is a less complex therapy, 
readily available and more cost-effective.  
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Furthermore, it is important to remember that the majority of the research relates to 
clinical sleep disturbance or insomnia. As argued earlier, it is unclear whether similar 
treatment benefits will be found in a non-clinical sleep disturbance population.  
Therefore, the current study aims to make a further contribution by examining the 
effectiveness of CBT-I in the form of self-help for patients with non-clinical sleep 
disturbance and various chronic health conditions for sleep patterns as well as the 
effect of this treatment on anxiety, depression and stress symptoms, sleep-related 
dysfunctional cognitions and HRQoL.   
 
 
2.8. Summary of the existing literature   
 
Insomnia is the most prevalent sleep disorder and, clinically, is referred to as 
difficulty in initiating or maintaining sleep, and/or poor quality of sleep. Evidence 
shows that people who have chronic health conditions are more likely to have sleep 
problems, in particular insomnia, than a healthy population. Within the context of 
chronic health conditions, sleep problems can be influenced by various factors such 
as pain, or psychological and behavioural factors. We also know from the literature 
that these factors may have a reciprocal relationship among patients with various 
chronic health conditions and insomnia since there is no clear direction of their 
causality (e.g. whether pain affects sleep or vice-versa). Also, insomnia is associated 
with a reduced health-related quality of life in patients with chronic health conditions 
and increased health care costs. Overall, the evidence suggests that sleep problems, 
especially insomnia, are common among patients with various types of chronic 
health conditions and may negatively affect symptoms of their condition or 
conversely, the symptoms of their chronic health condition may further trigger and 
maintain sleep problems.  
Various treatment options are available for the management of sleep problems 
including pharmacological and herbal remedies and dietary supplements. 
Pharmacological treatments prove to be effective in the short term, whereas their 
long-term use is associated with serious adverse effects.  
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However, the evidence is limited regarding the effectiveness of herbal remedies and 
dietary supplements. Over time, a variety of alternative treatments for sleep problems 
has become available, focusing on targeting factors that precipitate and perpetuate 
sleep problems, such as psychological factors. Initially, the most commonly applied 
interventions were behavioural-oriented interventions, including stimulus control 
therapy, a variety of relaxation therapies, sleep restriction and educational sleep 
hygiene therapy in treating sleep problems. 
One of the difficulties of such interventions is that they are relatively restrictive 
approaches since they do not have a framework that allows us to entirely address the 
various factors (e.g. dysfunctional cognitions) subsumed in the 3-P model 
(Spielman’s 1986; Spielman & Glovinski, 1991; Morin, 1993). As a result, a more 
hybrid and comprehensive approach has been developed, known as cognitive 
behavioural therapy for insomnia (CBT-I) that addresses both behaviours (e.g. 
maladaptive sleep habits) and cognitions (e.g. dysfunctional beliefs about sleep) that 
may play a role in triggering and maintaining sleep problems. CBT-I has been 
considered the treatment of choice for improving sleep in patients with primary 
insomnia and recent studies have shown its effectiveness in patients with various 
chronic health conditions. Also, Morin (2003) suggests that, since insomnia is 
associated with morbidity, an effective treatment should not only improve sleep but 
also improve psychological adjustment and quality of life. The research reviewed 
above has provided mixed findings in relation to psychological adjustment (e.g. 
depression, anxiety) and improved health-related quality of life. On the one hand, 
some studies indicate that CBT for insomnia is effective in reducing anxiety, 
depression and improving health-related quality of life. On the other hand, other 
findings suggest that CBT is not effective in improving such outcomes. Although, 
the results are mixed in relation to psychological adjustment and improved health 
related quality, CBT is effective in improving sleep. A major barrier to the 
application of CBT is that it has limited accessibility in practice, due to the lack of 
trained CBT therapists and the associated high costs of delivering such treatment.  
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Recently, Espie (2009) proposed the 5-level stepped care model for CBT-I to deal 
with these barriers. Espie’s (2009) model recommends the delivery of CBT in the 
form of self-help as a first option in stepped care. Recent evidence shows that CBT-I 
SH is an effective and applicable treatment both in clinical and non-clinical 
populations with insomnia.  
 
 
2.8.1. Problem with the literature and scope of the study  
 
The existing literature tends to focus particularly on individuals with clinical sleep 
disturbance or insomnia showing the complexity of the relationship between 
insomnia and psychological factors (e.g. depression may cause insomnia or vice 
versa), sleep-related dysfunctional beliefs and impaired health-related quality of life. 
However, individuals with non-clinical sleep disturbance and chronic health 
conditions have been largely overlooked. Therefore, it is not clear whether a such 
relationship (e.g. anxiety, depression, sleep-related dysfunctional beliefs etc.) co-
exists in individuals with non-clinical sleep disturbance and various chronic health 
conditions. It is important to establish a possible relationship among patients with 
chronic health conditions and non-clinical sleep disturbance, and it is also of high 
importance to further use this understanding in order to improve people’s lives by 
providing beneficial and effective treatments such as CBT. Whereas, to date, much 
of the research shows that CBT-I in the form of a self-help booklet is an effective 
and applicable treatment for patients with insomnia with or without chronic health 
conditions, it is unclear whether a CBT self-help booklet is also effective for patients 
with non-clinical sleep disturbance and chronic health conditions.  
Hence, the current study is of particular importance and will contribute to the 
existing literature by taking a step forward, by evaluating the clinical effectiveness of 
multicomponent CBT for sleep problems in a unique participant sample of patients 
with chronic health conditions and non-clinical sleep disturbance.  
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Evidence derived from research involving patients with a chronic health condition 
and clinical insomnia suggests that a brief course of CBT-I may be a relevant and 
beneficial treatment for the management of non-clinical sleep disturbance in patients 
with chronic health conditions. Also, it was presumed that an easily accessible, brief, 
less complex and affordable CBT-I intervention would be considered beneficial to 
meet the needs for this group of patients. Hence, CBT–I in the form of self-help 
meets these requirements and may represent the most beneficial choice as an initial 
step treatment option for this type of population with sleep disturbance problems.   
 
 
2.9. Aims and Hypotheses 
 
The aims of the current study are: 1) to explore whether individuals with non-clinical 
sleep disturbance at baseline have poor sleep quality, insomnia symptoms and as 
well high levels of psychological distress (anxiety, depression and stress), sleep-
related dysfunctional beliefs and impaired health-related quality of life, and 2) to 
assess the effectiveness of CBT-I in the form of a published self-help booklet in a 
non-clinical sleep disturbance population with at least one chronic health condition. 
In particular, we aim to evaluate the potential ‘real world’ implementation of a brief 
CBT-I self-help booklet across a range of patients who self-reported sleep-related 
problems (or sleep disturbance) with chronic health conditions including various 
rheumatology diseases and irritable bowel syndrome to alleviate sleep disturbance.  
It is important to assess whether in fact this is the case.  
Therefore, based on the aforementioned considerations, the following hypotheses are 
proposed:  
Hypothesis I: Participants with non-clinical sleep disturbance at baseline will report 
poor sleep quality, high levels of insomnia severity, anxiety, stress and depression 
symptoms, sleep-related dysfunctional beliefs as well as impaired health related 
quality of life. 
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Hypothesis II: A brief CBT-based self-help booklet for sleep problems and 
insomnia will improve quality of sleep and reduce levels of insomnia severity in non-
clinical disturbance patients with chronic health conditions who report either 
insomnia or mild sleep disturbance. 
 
Hypothesis III: Participants with non-clinical sleep disturbance who experience 
significant improvements in sleep will exhibit a reduction in symptoms of anxiety, 
depression and stress and sleep-related dysfunctional beliefs and will improve health-
related quality of life.  
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3. METHOD 
 
 
3.1. Introduction 
  
This chapter describes the methodological procedures that were undertaken to 
address the hypotheses of the current study.  
Firstly, it outlines the approval procedures of the study, followed by a detailed 
description of the selection of participants, and recruitment approach process, the 
assessment measures, the intervention material and the statistical analyses that were 
implemented in the study. 
 
 
 
3.2. Approvals 
 
 
3.2.1. NHS Ethical and Management Approvals and Copyrighted 
Permissions 
 
Full ethical approval was granted by the NHS Lothian Local Research Ethics, South 
East Scotland Research Ethics Committee 1: Reference number: 12/SS/0114 (see 
Appendix 1). Also, NHS Management approval (see Appendix 2) was obtained from 
the NHS Lothian, Queen’s Medical Research Institute, Edinburgh prior to the data 
collection. Copyrighted formal permissions for use of the measurements included in 
the study were obtained from the developers of the questionnaires. Permission was 
also obtained for the use of the CBT self-help booklet for the current study from the 
publisher of the booklet.  
 
 
3.2.2. Ethical Considerations 
 
Data collection for the study was conducted in accordance with the stipulations laid 
down by the NHS Research Ethics Committee (REC) and the Research and 
Development (R&D) in Scotland. Additionally, the British Psychological Society 
Code of ethics (BPS, 2009) and Health and Care Profession Council (HCPC) (2008) 
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were followed at all times in order to ensure that participants’ rights were not 
breached and their safety was maintained.  
For example, the standards of informed consent were addressed by providing a clear 
Participant Information Sheet and a Consent Form and by ensuring that all potential 
participants approached had ample time to discuss with others before making a 
decision on whether or not to participate in the study.  
Confidentiality was addressed by attributing a unique code to each participant’s data 
and by keeping any manual and electronic data in secure locations within the NHS 
(e.g. in a locked cabinet or on the NHS home drive) to comply with the Data 
Protection Act (1988).  
 
 
3.3. Participants  
 
 
3.3.1. Inclusion Criteria  
 
Potential participants (both male and female) were patients attending an appointment 
with their consultants. To be included in the study, participants were required to 
satisfy the following inclusion criteria: 
 
1) To be diagnosed with a chronic health condition as defined by the 
Department of Health (2012) (see section 2.2.)  
2) To be referred by their medical consultants  
3) To be at least 18 years old  
4) To have self-reported sleep disturbance 
5) To speak sufficient English to be able to understand the printed material  
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3.4. Recruitment  
 
 
3.4.1. Study Site 
  
Participants were recruited between April 2013 and March 2014 from two different 
outpatient clinics at Western General Hospital, Edinburgh, Scotland: (a) the 
Gastroenterology Tertiary Care outpatient clinic and (b) the Rheumatology 
outpatient clinic.   
 
 
 
3.4.2. Approach-Recruitment   
 
Potential participants were informed about the study by their medical consultants 
during their appointments. Those expressing an interest in the study were then 
referred by their consultants to the researcher, with whom they had the opportunity to 
discuss the research with the researcher prior to consenting to participate.  
The researcher provided a brief oral description of the study’s aims and procedures 
and answered direct questions. Those who self-reported sleep problems and who 
expressed an interest in participating in the study were given a package containing a 
detailed Participant Information Sheet (see Appendix 3), the Consent Form (see 
Appendix 4), the baseline questionnaires and a stamped addressed envelope for 
returning the signed Consent Form and completed questionnaires. Participants were 
advised to read the Participant Information Sheet carefully at home and told that they 
could omit answers to questions they did not wish to complete. Also, the researcher 
provided her contact details as well as the contact details of an independent advisor 
for those who required any further information or if any of the information on the 
Participant Information Sheet was not clear to them. Furthermore, the researcher 
asked for oral consent to telephone participants to remind them to return their 
completed questionnaires by post.  
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3.5. Procedure  
 
Upon receipt of the completed questionnaires and Consent Form, an intervention 
letter (i.e. to serve as a reminder of what the study was about and what procedures 
participants were being requested to follow (see Appendix 5) and the CBT self-help 
booklet entitled ‘An Introduction to Coping with Insomnia and Sleep Problems’ 
(Espie, 2011) were sent by post to the participants. A more detailed description of the 
content of the self-help booklet is presented in the section 3.7.  
Participants were requested to read the self-help booklet carefully and to practise the 
techniques described in the booklet for the following six weeks. Furthermore, they 
were requested to monitor how frequently they used the CBT self-help booklet 
during each of the six weeks by using a diary that was attached to the self-help 
booklet. Upon completion of the 6-week intervention, the same questionnaires 
accompanied by an intervention evaluation questionnaire were sent by post to the 
participants.  
Participants were asked to complete these questionnaires and to return them to the 
researcher in the enclosed stamped addressed envelope the following week. 
 
 
 
3.6. Measures  
 
3.6.1. Demographic Characteristics Questionnaire  
 
At the commencement of the study, participants completed the demographic 
characteristics questionnaire, which was created by the researcher to obtain 
information on variables such as gender, age, educational level, marital status, 
ethnicity, work status and other important information (e.g. type and length of 
medical diagnosis, severity of their sleep problem, if they are currently receiving any 
psychological treatment for sleep problems, etc.)  (see Appendix 6).  
 
In addition, the following standardised questionnaires were administrated before and 
after the intervention:  
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3.6.2. Pittsburgh Sleep Quality Index (PSQI) 
 
The Pittsburgh Sleep Quality Index (Buysse et al., 1989; see Appendix 7) was used 
here since it is one of the recommended measures for assessing general sleep 
disturbance (Buysse et al., 2006). The PSQI questionnaire assesses general sleep 
disturbances over a 1-month time interval. The PSQI contains 19 self-rated questions 
generating seven component scores: (1) Duration of sleep, (2) Sleep disturbance, (3) 
Sleep latency, (4) Day dysfunction due to sleepiness, (5) Sleep efficiency, (6) 
Subjective sleep quality and (7) Use of Sleep medications.  
The first four questions are open-ended, whereas questions 5 to 19 are rated on a 4-
point Likert scale from 0 (no difficulty) to 3 (severe difficulty). The overall score is 
obtained by summing the seven subscales with a possible minimum score of 0 and a 
possible maximum score of 21. A total PSQI score higher than 5 is associated with 
poor sleep quality. There are no available cutoff scores for the component scales. 
The PSQI has good internal consistency with Cronbach’s α=0.83 and reliability 
coefficient of r=. 85 (Buysse et al., 1989). Also, the PSQI has good internal 
consistency with Cronbach’s α=0.80 in patients with various chronic health 
conditions with good or poor sleep quality (Carpenter & Andryskowski, 1998).  
 
 
3.6.3. Insomnia Severity Index  (ISI) 
 
The Insomnia Severity Index (Bastein, Vallieres & Morin, 2001; Morin, Belleville, 
Belanger & Ivers, 2011 see Appendix 8) is a recommended measure for measuring 
the perceived severity of insomnia symptoms (Buysse et al., 2006). The ISI contains 
the following categories: a) Severity of sleep-onset, sleep-maintenance and early 
morning awakenings, b) Degree of dissatisfaction with the current sleep pattern c) 
Noticeability of sleep problems by others, d) Level of distress or worry caused by the 
current sleep problems, and e) Degree to which sleep problems interfere with daily 
functioning. The items are answered on a 5-point Likert scale ranging from 0 (no 
problem) to 4 (very severe problem). The total score is obtained by adding the seven 
items ranging from 0 to 28 and is interpreted as follows: 0-7, no clinically significant 
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insomnia; 8-14, sub-threshold insomnia; 15-21, clinical insomnia of moderate 
severity; 22-28, severe clinical insomnia. The ISI has good overall internal 
consistency for both community and clinical samples with Cronbach’s α = 0.90 and 
0.91 respectively.  
 
 
3.6.4. Dysfunctional Beliefs and Attitudes about Sleep Scale-16 Item 
Version (DBAS-16) 
 
The DBAS-16 (Morin, Valliers & Ivers, 2007; see Appendix 9) is an abbreviated and 
the latest version of the original DBAS-30 (Morin, 1994) and the most commonly 
used questionnaire (Carney et al., 2010) in assessing the existence and level of 
dysfunctional beliefs concerning sleep. Items are rated using a Likert-type scale from 
0 (strongly disagree) to 10 (strongly agree). The total score is calculated using the 
average score of all 16 items with a higher score indicating a higher level of 
dysfunctional beliefs and attitudes about sleep.   
The psychometric properties of DBAS-16 are adequate (Morin et al., 2007). In 
clinical samples the internal consistency was reported as α=. 77 and test–retest 
reliability coefficient of r= .83 (Morin et al., 2007).  
 
 
3.6.5. Depression Anxiety and Stress Scale-21 (DASS-21)  
 
The DASS-21 (Lovibond & Lovibond 1995; see Appendix 10) was selected for use 
in the current study since it assesses the three negative emotional states: a) 
depression, b) anxiety and c) stress that are related to sleep.  Items are rated using a 
4-point Likert scale from 0 (did not apply to me at all) to 3 (applied to me very 
much, or most of the time). It consists of a set of three self-report scales designed to 
assess anxiety, depression and stress respectively. Each scale contains seven items 
and the total score for each scale is obtained by summing the responses for the 
relevant items and multiplying them by 2.The Cronbach’s α for the depression, 
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anxiety and stress scales are 0.88; 082 and 0.90 respectively in a non-clinical 
population (Henry & Crawford, 2005).  
In addition, the DASS-21 is a valid and reliable measure in both clinical and non-
clinical samples (Antony, Bieling, Cox, Erns & Swinson, 1998). The DASS-21 can 
used both for research purposes and as a routine clinical outcome measure (Lovibond 
& Lovibond, 1995). 
 
 
3.6.6. Health-Related Quality of Life (SF-36v2) 
 
The SF-36v2 (Ware et al., 2008; see Appendix 11) is recommended for measuring 
HRQoL within the context of insomnia (Buysse et al., 2006) and for the current 
study the standard 4-week recall was used since it is more appropriate in cases where 
the questionnaire is administered once or after a period of four weeks (Ware et al., 
2008). The SF-36v2 is a 36-item questionnaire yielding a profile of health status 
across eight health domains: Physical Functioning (PF), Role Physical (RP), Bodily 
Pain (BP) General Health (GH), Vitality (VT), Social Functioning (SF), Role 
Participation with Emotional Health Problems (Role Emotional) (RE), and Mental 
Health (MH).  The SF36v2 items are rated using a Likert scale. For example, 25 
items are rated on a 5-point scale; 10 items are rated on a 3-point scale and one item 
is rated on a 6-point scale. A computer-based software package 4.5™ was used to 
score the SF-36v2 under licence from Quality Metric Incorporated. The eight health 
domains are computed and two summary scores are derived: a) a physical component 
summary (PCS) and b) a mental component summary (MCS). The PF, RP, BP and 
GH are more strongly correlated with the PCS factor, which contributes more 
towards to the PCS score. On the other hand, the VT, SF, RE and MH are more 
strongly correlated to the MCS factor which contributes more to the MCS score.     
The scores are translated from 0 (lowest score) to 100 (highest score). Higher PCS 
and MCS scores indicate a better health-related quality of life. Cronbach’s α is not 
calculated for PCS and MCS because these summary measures are linear 
combinations of the eight scales. Τhe reliability coefficient for the PCS and MCS are 
.96 and .93 respectively (Maruish, 1993).  
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3.7. The CBT Intervention  
 
The self-help booklet: ‘An Introduction to Coping with Insomnia and Sleep 
Problems’ (Espie, 2011, see Appendix 12) comprises two parts.  
The first part of the booklet, entitled ‘About Insomnia’, aims to help patients to 
understand in detail what insomnia is, to help them identify other sleep disorders, 
and to understand the relationship between poor sleep and low mood. It explains 
what causes insomnia (e.g. predisposing, precipitating and perpetuating factors) and 
what the different treatments for insomnia are, e.g. medication, psychological 
therapies (CBT) and other therapies, e.g. herbal remedies.    
 
The second part of the booklet, entitled ‘Coping with Insomnia’, provides a 
preliminary introduction to the self-management approach to insomnia (such as 
setting personal goals, maintaining a sleep diary, and the calculation of sleep 
efficiency), followed by different strategies that patients can use to improve their 
sleep. These include improving sleep hygiene (e.g. explaining what sleep hygiene is, 
the lifestyle and bedroom factors associated with good sleep hygiene), improving 
preparation for sleep (e.g. bedtime wind-down, learning to relax), improving the bed-
sleep connection (e.g. the bed is for sleep rule, the quarter of an hour rule), making 
your sleep pattern the best it can be, dealing with a racing mind (dealing with 
negative thoughts), evaluating how you feel during the day, and trying to make 
lasting improvements to sleep.  
Lastly, the CBT-I SH booklet also includes other sources of information that might 
help (e.g. websites and other books pertaining to self-management of sleep 
problems) (see Table 1.1).  
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Table 1.1 
Content of the CBT-I Self-Help Booklet  
 
Booklet titles and subheadings Summary of contents 
Part 1: About insomnia 
What is insomnia? 
What causes insomnia? 
Different treatments for insomnia  
 
Understand what insomnia means; it helps to 
identify other disorders of sleep; sleep and mood 
relationship; prevalence of insomnia; factors 
causing insomnia (predisposing, precipitating and 
perpetuating factors); different treatments of 
insomnia (e.g. medications, herbal remedies and 
CBT) 
 
Part 2: Coping with Insomnia 
 Setting clear goals  
 
Improving sleep hygiene  
Improving your preparation for sleep  
Improving your bed-sleep connection 
Making your sleep pattern the best it 
can be  
 
Dealing with a racing mind  
 
Evaluating how you feel during the 
day  
 
Making lasting improvements to your 
sleep  
 
Self-management: personal goals; keeping sleep 
diary; calculating sleep efficiency 
Explain what Sleep Hygiene is  
Learning to relax: Physical and Mental relaxation  
Stimulus control  
Setting and Adjusting your sleep window; Sleep 
Restriction  
 
Cognitive therapy: thought diary; setting realistic 
expectations about sleep  
Use the thought evaluator to deal with your 
daytime thinking  
 
Encouraging and advising to continue with all the 
CBT techniques 
 
Other things that might help  Other sources of information: e.g. more detailed 
self-help books and different websites  
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3.7.1. Diary 
 
Attached to the self-help booklet is a diary entitled ‘Frequency of use of the CBT 
self-help guide’. Participants were asked to indicate whether they used the CBT self-
help booklet daily, 3-5 times, 1-2 times, or not at all. They were also asked to 
estimate the total use each week in hours and minutes (see Appendix 13).  
 
 
3.7.2. Participant Evaluation: Treatment Satisfaction  
 
Following completion of the intervention, participants also completed a brief 
evaluation questionnaire comprising nine close-ended questions requiring them to 
respond by using a 5-point Likert scale and three open-ended questions to enable the 
researcher to evaluate participants’ perceptions of the self-help booklet with regard 
to alleviating their sleep problems (e.g. expectations, satisfaction or difficulties in the 
use of the self-help booklet) (see Appendix 14).     
 
 
3.8. Study Design  
 
A within subject/repeated-measures design was implemented to evaluate the 
effectiveness of the intervention. Within subject design is a design in which the same 
group of participants participates in all conditions (Shuttleworth, 2009). For the 
current study, two time points were used: a) before the intervention and b) after the 
intervention. The advantages of a within subject design are: a) it requires fewer 
participants and resources and b) it reduces the effects of natural variation among 
participants upon the results (Shuttleworth, 2009).  
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3.9. Data Analyses  
 
A series of t-tests/paired-samples t-tests were conducted for all outcome measures to 
compare the pre-treatment and post-treatment mean scores of the two related groups 
to detect whether there are any statistically significant differences between these 
means.  
 
 
3.10. Sample size 
 
3.10.1. Power calculation and sample size  
 
An a priori sample calculation was conducted using the G* power program (Faul, 
Erdfelder, Lang, & Buchner, 2007; Faul, Erdfelder, Buchner & 2009) to determine 
how many participants were needed for a repeated measures design. To detect an 
effect size of 0.3 (small effect) with a statistical power of 0.8 (80%), the G*power 
program suggested at least 90 participants. It was anticipated that one would recruit 
approximately 120 participants in order to allow for a 25% dropout rate. The QMU 
statistician also confirmed the sample calculation size. However, the estimated 
sample was not achieved and the reasons related to this are described below.  
 
A flow diagram (Figure 1.1) is presented on the following page, which shows the 
recruitment, participation and completion phases of all study components.               
Of 287 participants who expressed an interest in the study, 114 participants 
completed baseline questionnaires and received the intervention. In total, 50 
participants successfully completed all the study components. However, one 
participant was later excluded from the final analyses due to incomplete assessments 
resulting in an overall sample size of 49 participants.  
The remaining 64 participants withdrew from the trial for the following reasons:  
illness flare-ups, surgery, hospitalisation, workload demands, family stressors, or 
being away on holiday. In addition, a further five participants were excluded due to 
incomplete data and/or other reasons (e.g. they requested to be excluded from the 
study).  
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Figure 1.1 Flow diagram of recruitment, participation and completion of all study 
components.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 287 patients 
invited 	  
114 agreed to 
participate  	  
Did not drop out (n=50) 
Total final sample - analysed  
pre and post the intervention  
(n=49) 
 
Total excluded from analysis 
(n=1) 
• Due to incomplete data 	  
Dropped out (n=64) 
Total final sample -analysed 
pre-intervention  (n=59) 
 
Total excluded from analysis 
(n=5) 
• Due to incomplete data 
(n=2) 
• Other reasons (n=3) 	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4. Results 
 
 
4.1. Data Screening  
 
Data were analysed using the statistical software for the Social Sciences, SPSS for 
Windows (Version 21.0, Armonk, NY: IBM Corp.). Prior to analyses, data were 
screened for missing values. In cases where no more than two items/answers were 
missing in a multi-item scale (e.g. a 16-item scale) and where no more than one 
item/answer was missing in a 7-item scale, the missing values were adjusted.  
For the adjustment, the formula Y=(z x N)/M was used, where z was the score for 
questions answered M was the maximum score for the number of questions answered 
N was the maximum score for all questions, Y was the score as if all questions had 
been answered (this procedure was adopted following personal communication with 
Dr. Robert Rush, QMU, statistician). This procedure resulted in an overall variation 
across the total number of cases. For example, in some cases, analyses were based on 
data for 47 or 48 participants (see Table 1.2). However, this procedure was not 
applied for the PSQI due to the scoring instructions of the questionnaire.  
An assessment of the normality of all continuous outcomes was performed using the 
Shapiro-Wilk test. The distribution of all included variables across the two time 
points (pre-and post-intervention) was assessed for normality. Parametric tests were 
used for cases that were normally distributed, whereas in cases where the data were 
not normally distributed, non-parametric tests were used.  
 
 
4.2. Participants’ demographic characteristics  
 
As stated previously in section 3.9.1. a total of 49 participants completed the 
intervention. The majority of the participants were female (89.8%; n=44) of Scottish 
ethic origin (81.6%; n=40) and the mean age of the participants was 56.20 years 
(range= 22 to 80 years; SD=14.3). Age was normally distributed. Thirty-three 
participants (67.3%) were married/cohabiting, whereas the remaining 16 (32.7%) 
reported being single, widowed or separate/divorced.  
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With regard to educational level, 19 participants (40.4%) reported having a higher 
educational level (college or university); 46.8% (n=22) had secondary school 
education (e.g. standard grades, SVQ/NVQ, Highers or Advanced Highers) and 
12.8% (n=6) indicated that they did not have any educational qualifications. 
Furthermore, 19 participants (39.6%) were retired; 12 (25.0%) were employed in a 
part-time position and four (8.3%) were employed in a full-time capacity.              
The remaining 12 (25%) participants were unemployed for reasons related to their 
chronic health condition and one participant (2.1%) was unemployed for reasons 
unrelated to their chronic health condition. Of those who reported working, seven 
participants (87.5%) indicated they were not night shift workers, while one 
participant (12.5%) reported that he was a night shift worker.  
Of the 49 participants, 10 (20.4%) had diagnosis of IBS and 39 (79.6%) had 
diagnosis of different rheumatoid diseases (such as rheumatoid arthritis, lupus). All 
participants self-reported that they had sleep problems and that they had experienced 
such problems from 2 months to over 40 years.  
With regard to sleep medications, 40 (83.3%) participants indicated that they were 
not taking any sleep medications and that they did not have any sleep problems prior 
to the onset of their chronic health condition.  
With regard to sleep-related problems, 26 participants (53.1%) reported that their 
sleep problems had started at the same time as the onset of their chronic health 
condition. Furthermore, 40 participants (83.3%) indicated that when the symptoms of 
their health condition flare-up, their sleep gets worse. More than half of the 
participants (63.8%) reported that when their chronic health condition goes through 
periods of improvement, their sleep also gets better.  
Participants reported that they did not receive any psychological treatment for sleep 
problems, though one participant reported that he had been using tapes to help him 
relax. Finally, 46 (93.9%) participants reported that they had excellent to good 
reading and comprehension abilities.  
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4.3. Descriptive Statistics of Participants’ Outcomes Measures at 
Baseline   
 
With regard to the first hypothesis, it was predicted that individuals with non-clinical 
sleep disturbance at baseline would have poor sleep quality and severe insomnia 
symptoms, as well as high levels of psychological distress (anxiety, stress and 
depression), sleep-related dysfunctional beliefs and poor health-related quality of 
life.  
Descriptive statistics (e.g. means and standard deviations) of participants for all 
survey measures at baseline are presented in Table. 1.2 on page 61.  
With regard to sleep quality as measured by PSQI (Buysse et al, 1989), 46 
participants (92.1%) reported poor sleep quality, while the remaining three 
participants (7.9%) reported good sleep quality.  
With regard to insomnia severity as measured by the ISI (Bastein et al, 2001;Morin 
et al., 2011), the mean score of 48 participants was 16.96, which is in the clinical 
moderate insomnia severity range. Specifically, the current sample included, one 
participant (2.1.%) with non-clinical insomnia, 15 participants (31.3%) with sub-
threshold insomnia, 22 participants (45.8%) with clinical moderate insomnia and 10 
participants (20.8%) with clinical severe insomnia (Bastein et al, 2001; Morin et al., 
2011). In sum, 47 participants reported either sub-threshold or clinically significant 
insomnia.  
With regard to the anxiety, depression and stress subscales (DASS-21; Lovibond, & 
Lovibond, 1995), the participants were classified with moderate anxiety, depression 
and stress with mean scores of 12.12 (n=48); 15.95 (n=48) and 19.85 (n=49) 
respectively (Lovibond & Lovibond 1995). In particular, for the anxiety subscale, 20 
participants (41.7%) were classified within normal range, one participant (2.1%) was 
classified with mild anxiety, 13 participants (27.1%) with moderate anxiety, three 
participants (6.3%) with severe anxiety and 11 participants (22.9%) were classified 
with extremely severe anxiety. With respect to the depression subscale, participants 
were classified as follows: 17 participants (35.4%) were classified within the normal 
range, nine participants indicated (18.8.%) mild depression, seven participants 
(14.6%) indicated moderate depression, four participants (8.3%) indicated severe 
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depression and 11 participants indicated (22.9%) extremely severe depression. 
Finally, regarding the stress scale, 17 participants (34.7%) were within normal range, 
eight participants (16.3%) reported mild stress, nine participants (18.4%) reported 
moderate stress, seven participants (14.3%) reported severe stress and eight 
participants (16.3%) reported extremely severe stress.  
 
The dysfunctional sleep-related beliefs (DBAS-16; Morin et al., 2007) and the 
health-related quality of life measurements (HRQoL SF: 36; Ware et al., 2008) have 
no published cut-off score. Therefore, the minimum and maximum scores were used 
for these measurements to indicate the severity of the problem. The minimum and 
maximum scores for the DBAS-16 ranged from 0 to 10 respectively; a higher score 
indicates higher levels of sleep-related dysfunctional beliefs. Participants reported 
means scores of 4.85, which suggest moderate levels of sleep-related dysfunctional 
beliefs.  
The scoring of the HRQoL for both physical and mental components indicates from  
0 (poorest quality of life) to 100 (best possible quality of life). The mean HRQoL in 
our sample was 34.7 and 41.3 for the physical and mental components respectively. 
Participants’ HRQoL (for both mental and physical components) was below 50, 
which suggested that they had significantly impaired HRQoL.  
 
In summary, the current results suggest that, of the individuals who had non-clinical 
sleep disturbance, the majority reported poor sleep quality, clinically moderate levels 
of insomnia severity and moderate to extremely severe levels of psychological 
symptoms (anxiety depression and stress), moderate sleep-related dysfunctional 
beliefs and impaired HRQoL.  Collectively, these findings suggest that the current 
population with non-clinical sleep disturbance could benefit from a brief CBT-
intervention in the form of a self-help booklet. The results of the effectiveness of the 
CBT intervention are presented on section 4.4.  
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Table 1.2  
Descriptive statistics of participants for survey measures at baseline 
Measure N M SD 
PSQI  38 11.8 3.82 
ISI  48 17 4.94 
DBAS-16 47 4.84 1.94 
DASS 21:Anxiety  48 12.1 10.7 
DASS-21: Depression  48 16 13 
DASS-21: Stress  49 19.9 10.8 
SF-36: PCS 48 34.7 9.86 
SF-36: MCS  48 41.3 12.6 
Note. PSQI=Pittsburgh Sleep Quality Index; ISI=Insomnia Severity Index; DBAS-16=Dysfunctional 
beliefs and attitudes about sleep; SF-36-PCS=Physical component; SF-36-MCS=Mental component 
 
 
4.4. Statistical Analyses 
 
4.4.1. Effects of the Intervention  
 
With regard to the second hypothesis, it was hypothesised that a brief CBT-based 
self-help booklet for sleep problems and insomnia would improve quality of sleep 
and reduce levels of insomnia severity in non-clinical disturbance patients with 
chronic health conditions who report either insomnia or mild sleep disturbance.  
With regard to the third hypothesis, it was hypothesised that participants with non-
clinical sleep disturbance who experience significant improvements in sleep will 
exhibit a reduction in symptoms of anxiety, depression and stress and sleep-related 
dysfunctional beliefs and will improve their HRQoL. Therefore, in order to examine 
the effectiveness of the intervention on these outcomes, a series of paired sample       
t-tests and Wilcoxon signed-rank tests were conducted to compare each of the 
outcomes before and after the intervention. The results are presented below.  
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4.4.2. Sleep Quality  
 
There was a significant difference between the pre-intervention total scores (M=11.7, 
SD=3.93) and the post-intervention total scores for sleep quality (M=9.26, 
SD=4.64), t(34) =4.10, p<.001 in 35 participants. Post-intervention scores were 
significantly lower, indicating better sleep quality. These results suggest that the 
intervention was effective in significantly improving sleep quality.   
 
Also, further analyses were conducted to identify which sleep quality components 
significantly contributed to overall improved sleep quality. Each sleep quality 
component score (e.g. duration of sleep, sleep disturbance, sleep latency, day 
dysfunction due to sleepiness, sleep efficiency, overall sleep quality, and need of 
medication to sleep) was compared before and after the intervention. The results 
indicated a significant decrease in the sleep disturbance component scores and 
improvements in overall sleep quality at post-treatment assessment (p<.001). Also, 
there was a significant increase in total sleep time per night (p=.034) and both sleep 
quality components of sleep latency (p= .042) and day dysfunction due to sleepiness 
(p=.031) showed significant differences before and after the intervention.  
However, sleep quality components scores with regard to the need for sleep 
medications (p=.552) and sleep efficiency (p=.083) showed no significant 
differences before and after the intervention.  
  
 
4.4.3. Insomnia Severity Index  
 
There was a significant difference between the pre-intervention total scores (M=17. 
1, SD=4.90) and post-intervention total scores for insomnia severity (M=13.7, 
SD=6.58), t(46)=4.41, p<.001 in 47 participants. Post-intervention insomnia severity 
scores were significantly lower. These results suggest that the intervention was 
effective in reducing insomnia severity.  
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4.4.4. Dysfunctional Beliefs and Attitudes about Sleep 
  
There was a significant difference between the pre-intervention total scores (M=4.92, 
SD=1.89) and post-intervention total scores for dysfunctional sleep-related beliefs 
(M=4.39, SD=2.05), t(45)=2.38, p=.022 in 46 participants. Post-intervention 
dysfunctional sleep-related beliefs scores were significantly lower. The results 
suggest that the intervention significantly reduced sleep related dysfunctional beliefs.  
 
 
4.4.5. Stress  
 
There was a significant difference between the pre-intervention total scores and     
post-intervention total scores for stress z=-2.653, p=.008 in 49 participants. The 
results suggest significantly lower levels of stress.  
 
 
4.4.6. Anxiety  
 
There was no significant difference between the pre-intervention total scores and 
post-intervention total scores for anxiety, z=-1.409, p=.159 in 48 participants.  
 
 
4.4.7. Depression  
 
There was no significant difference between the pre-intervention total scores and 
post-intervention total scores for depression, z=-1.812, p=.070 in 48 participants.  
 
 
 
 
 
 
	   64	  
4.4.8. Health-Related Quality of Life (HRQoL) 
 
4.4.8.1. HRQoL: Physical Health Component  
 
There was no significant difference between the pre-intervention total scores 
(M=34.7, SD=9.86) and post-intervention total scores for physical component 
(M=35.9, SD=9.73), t(47) =-1.56, p=. 125 in 48 participants.   
 
 
4.4.8.2. HRQoL: Mental Health Component  
 
Similarly, the results indicated that there were no significant difference between the 
pre-intervention total scores (M=41.3, SD=12.6) and post-intervention total scores 
for mental component (M=41.9, SD=12.4), t(47) =-.507,  p=.614 in 48 participants.   
 
 
In sum, participants who completed a brief CBT self-help booklet intervention for 
sleep showed an improvement in overall sleep quality and reductions in symptoms of 
sleep-related dysfunctional beliefs, insomnia severity and stress following the 
intervention. However, no significant improvements were found in HRQoL (for both 
physical and mental components). In addition, there were no significant reductions in 
symptoms of anxiety and depression following completion of the intervention.   
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Table 1.4 
 
Pre and Post Treatment Measures for CBT  
 
 Pretest Posttest   
Outcomes  Mean Ranks Mean ranks z r 
Stress 
 20.25 24.24 -2.653*                     
 
-.38 
Anxiety  
 17.65 18.20 -1.409 
 
-.20 
 
 
Depression  
 
18.09 23.82 -1.812 
 
-.26 
 
Note: Z score for Wilcoxon t-test  
 *p < .05 
 
	  
	  
Table 1.3  
 
Pre and Post Treatment Measures for CBT  
 
 Pretest  Posttest   
Outcomes M SD  M SD t r 
Sleep Quality (PSQI)  11.7 3.93  9.26 4.64 4.107* .57 
 
Insomnia Severity (ISI) 
 
17.1 4.90  13.7 6.58 4.418* .54 
 
Beliefs and Attitudes about 
Sleep  (DBAS-16) 
4.92 1.89  4.39 2.05 2.380* .33 
 
PC-HRQoL (SF-36 Physical 
Health Component)  
34.7 9.86  35.9 9.73   -1.561 .22 
 
MC-HRQoL (SF-36Mental 
Health Component)  
41.3 12.6  41.9 12.4 -.507 .07 
Note:  M=Mean; SD=Standard Deviation; T score for paired t-test; r=Effect size 
p<.05 
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4.5. Further Explanatory Statistical Analysis  
 
Further explanatory analyses were performed to determine whether a particular 
group of participants in the sample benefited from the intervention. Since the current 
intervention was self-administrated CBT without any professional support, it 
required a good level of literacy and education in order to understand the written 
material and to use and practice the techniques described in the CBT self-help 
booklet to improve sleep.  
Therefore, post-treatment total scores were subtracted from the pre-treatment total 
scores of sleep quality (PSQI). Based on this equation, a new variable was created 
(PSQI-change scores). Subsequently, an independent sample t-test was performed to 
examine whether there are any significant differences between PSQI changed scores 
and education levels (e.g. higher education and secondary education).    
 
 
4.5.1. Sleep Quality Changed Scores and Education Levels   
 
Participants with a higher educational level had improved sleep quality (M=-3.80, 
SD=3.41) compared to those with a lower (secondary) educational level (M=-.933, 
SD=3.39), t(28)=-2.310, p=.028.  
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4.6. Intervention Evaluation and Frequency of use of the CBT Self-Help 
booklet  
 
4.6.1. Participant Evaluation: Treatment Satisfaction  
 
Overall, approximately 50% of participants rated the intervention good and 41.3% 
stated that they would probably recommend the use of the CBT-I self-help booklet to 
other people with sleep problems. A detailed summary of participant acceptability 
and satisfaction with the treatment as well as the estimated total usage of the CBT 
self-help booklet for each week is presented in the Appendices (see Appendix 15 & 
16 respectively).  
 
 
4.7. Assessment of Attrition  
 
4.7.1. Comparison of demographic profiles of participants who did and 
who did not dropout 
 
The demographic profiles of participants who did and did not dropout are presented 
in Table 1.5.  
Further analyses were performed using the demographic profiles and baselines scores 
of participants who did and did not drop out in order to determine if there were any 
differences with regard to the demographic profiles and baseline scores between the 
two groups. Prior to any analysis, normality tests were performed for the continuous 
variables (e.g. age) for both groups. Age was normally distributed.  
Consequently, an independent sample t-test was performed to examine if there were 
any significant differences with regard to age between the two groups.  
The results suggested that there were no significant differences between these two 
groups in relation to age (see Table 1.5).   
Concerning the categorical variables (gender, education, type of chronic health 
condition and marital status), Pearson chi-square tests were performed to examine if 
there were any differences between the two groups.  
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The results suggested that there were no differences between the two groups with 
regard to gender, education, type of condition and marital status (see Table 1.5). This 
indicates that demographic characteristics were not related to the dropout rate.  
 
 
Table 1.5 
Demographic profiles: Comparison of participants who did and did not dropout 
 
 
Variable(s) 
Continuous 
Dropped out Did not dropout p 
Age (Years) 
Mean ± SD 
53.39±15.01(59) 56.20±14.27(49) .324 
Categorical N (%) N (%) p 
Gender  
 
   
Male  14 (23.7%) 5 (10.2%) .066 
Female  45 (76.3%) 
 
44 (89.8%)  
    
Education level  
 
   
Higher education 16 (28.1%) 19 (40.4%) .398 
Secondary education  31 (54.4%) 22 (46.8%)  
No education  10 (17.5%) 6 (12.8%)  
    
Type of condition  
 
   
IBS 21 (35.6%) 10 (20.4%) .082 
Rheumatoid diseases  38 (64.6%) 39 (79.6%)  
    
Marital status    
    
Married/cohabiting  36 (62.1%) 33 (67.3%)  
Single/widowed/separate 
/divorced  
22 (37.9%) 16 (32.7%) .570 
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4.7.2. Comparison of Baseline Psychological Profiles of Participants 
who did drop out and those who did not dropout of the study  
 
Data were assessed for normality using the Kolmogorov-Shapiro and the Shapiro-
Wilk test. Pre-treatment assessment total scores (Sleep quality, Insomnia Severity 
Index, dysfunctional beliefs and attitudes about sleep, anxiety, stress, depression and 
health-related quality of life) were compared for the two groups to determine 
whether any of the variables differentiated these two groups. The results suggested 
that the two groups did not differ across any of the study variables (see Table 1.6 & 
Table 1.7). This indicates that the results are not biased and were not related to the 
dropout rate.  
 
Table 1.6 
Comparison of baseline psychological profiles of participants who did and did not 
dropout.  
Baseline                  Dropped out                           Did not Dropout  
Variables       (N) M  SD (N) M SD t p 
PSQI 50 12.8 3.39 38 11.8 3.82 -.1.215 .228  
ISI 58 17.5 5.40 48 17 4.94 -.548 .585 
DBAS 58 5.27 1.88 47 4.84 1.94 -1.143 .256 
Stress 57 19.5 11.8 49 19.9 10.8 .174 .862 
SF-36: PCS   58 33.3 11.2 48 34.7 9.86 .674 .500 
SF-36: MCS   58 41.6 12.4 48 41.3 12.6 -.159 .874 
Note. Independent t-test 
PSQI=Pittsburgh Sleep Quality Index; ISI=Insomnia Severity Index; DBAS-16=Dysfunctional beliefs 
and attitudes about sleep; SF-36: PCS=Physical component; SF-36:MCS=Mental component 
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In sum, the current results show that non-clinical sleep disturbance patients with 
chronic health conditions had poor sleep quality, clinically moderate levels of 
insomnia severity and moderate levels of psychological distress (e.g. anxiety, 
depression and stress) and moderate levels of sleep-related dysfunctional beliefs as 
well as impaired HRQoL. With regard, to the effects of the intervention, the results 
suggest that a brief CBT-SH booklet can significantly improve sleep patterns and 
reduce both sleep-related dysfunctional beliefs and stress symptoms among patients 
with non-clinical sleep disturbance and chronic health conditions. However, this 
group of patients did not show reductions in symptoms of anxiety and depression and 
improved HRQoL.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1.7 
 
Comparison of baseline psychological profiles of participants who did and did not 
dropout  
 
Baseline                 Dropped out                 Did not Drop Out  
Variables  (N) Mean 
Ranks  
 
 
(N) Mean 
Ranks  
U  p 
Anxiety  
 
58  56.3 48 50.0 1226 .292 
Depression  57 53.2 48 52.7 1355 .933 
 
Note. Mann-Whitney t-test 
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5. DISCUSSION 
 
 
The main aims of this study were to assess: 1) whether individuals with non-clinical 
sleep disturbance at baseline had poor sleep quality, severe symptoms of insomnia, 
high levels of psychological distress (anxiety, depression and stress) and sleep-
related dysfunctional beliefs as well as poor health-related quality of life, and           
2) whether a brief CBT-I self-help booklet was effective in a non-clinical sleep 
disturbance population with at least one chronic health condition, recruited from two 
Rheumatology and Gastroenterology hospital outpatient clinics. Considering 
individuals who self-report sleep disturbance is of particular importance since any 
sleep complaint may be perceived as problematic.  
To achieve the aims of the current study, three main hypotheses were addressed. 
Firstly, that individuals with non-clinical sleep disturbance at baseline will 
demonstrate high levels poor sleep quality, high severe insomnia symptoms, high 
levels of psychological distress (anxiety, depression and stress), sleep-related 
dysfunctional beliefs and poor health-related quality of life.  
Secondly, that a brief CBT based self-help booklet for sleep problems and insomnia 
will improve quality of sleep and reduce levels of insomnia severity in non-clinical 
disturbance patients with chronic health conditions who report either insomnia or 
mild sleep disturbance.  
Thirdly, that participants with non-clinical sleep disturbance who experience 
significant improvements in sleep will experience a reduction in symptoms of 
anxiety, depression and stress and sleep-related dysfunctional beliefs, and improved 
health-related quality of life. The findings for each hypothesis are discussed below.  
 
With respect to the first hypothesis, the results supported that the non-clinical sleep 
disturbance population had poor sleep quality, insomnia symptoms and moderate 
symptoms of psychological distress (anxiety, depression and stress) and impaired 
health-related quality of life, suggesting that a brief CBT-I self-help booklet would 
be beneficial for this type of population. Consequently, in relation to the second aim 
of the effectiveness of the intervention and with regard to the second hypothesis, the 
results of the current study indicated that the provision of a brief, multicomponent 
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CBT-I SH booklet significantly helped participants to alleviate their sleep problems.  
In particular, the CBT-I SH booklet can significantly improve chronic health 
patients’ overall sleep quality and reduced insomnia severity symptoms (as measured 
by self-report questionnaires PSQI and ISI respectively). The explanatory analyses, 
which aimed to further assess which PSQI component contributed to overall sleep 
quality, revealed a significant reduction in perceived sleep disturbance and overall 
sleep quality, followed by better perceptions of total sleep time, sleep latency and 
day dysfunction due to sleepiness. However, sleep medication and sleep efficiency 
components did not show any significant difference towards improved overall sleep 
quality following the completion of the intervention.  
With respect to the third hypothesis, participants reported reduced levels of sleep-
related dysfunctional beliefs and a reduction of stress following the intervention. 
However, they did not show any significant reduction to their symptoms of anxiety 
and depression. In addition, participants did not show improved health-related 
quality of life following the intervention.  
 
To our knowledge, this is the first study examining the effectiveness of a CBT-I    
SH booklet with virtually no clinical support for non-clinical sleep with chronic 
health conditions. In sum, the current results showed that, despite the fact that the 
current sample was a non-clinical sleep disturbance population with chronic health 
conditions, these individuals showed poor sleep quality and moderate insomnia 
severity symptoms. Furthermore, the current sample was shown to have moderate 
psychological symptoms (e.g. anxiety, depression and stress) that differ from normal 
profiles. Accordingly, the results suggest that a brief CBT-I SH booklet without 
professional support may be effective in alleviating sleep problems, reducing sleep-
related dysfunctional beliefs and stress levels among patients with chronic health 
conditions. However, no significant results were found for anxiety and depression 
symptoms and health-related quality of life. The results of the effectiveness of the 
CBT self-help booklet are discussed in more detail below and further considered in 
relation to studies in the field.  
The findings of this study support previous studies that evaluated the effectiveness of 
similar multicomponent CBT-I (targeting both cognitions and behaviours) self-help 
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interventions for patients with comorbid insomnia (e.g. Morgan et al., 2012; 
Rybarczyck et al., 2011; Jermelov et al., 2012; Casault et al., 2015; Rybarczyck et 
al., 2005) and among a healthy population with insomnia (e.g. Mimeault & Morin, 
1999; Morin et al., 2005) with CBT-I self-help improving sleep. However, in making 
these comparisons, it is necessary to take into account the methodological or 
procedural differences between the studies. For example, previous studies in the 
related field have performed pre-intervention participation screening using different 
tools (e.g. clinical diagnostic criteria, and/or questionnaires) to determine insomnia, 
and they differ in sample composition (e.g. type of chronic health conditions, age) 
and type of measurements in sleep outcomes and secondary outcomes. In addition, 
the effectiveness of CBT-I self-help interventions varied in terms of the degree of 
therapist support. These methodological or procedural differences between the 
studies are critical since different methods, data and findings may lead to different 
conclusions.  
 
Previous studies have supported the effectiveness of CBT-I SH combined with 
minimal support (e.g. Mimeault & Morin, 1999; Jermelov et al., 2012; Casault et al., 
2015; Rybarczyck et al., 2011; Rybarczyck et al., 2005) or optional access to 
telephone support (e.g. Morgan et al., 2012; Morin et al., 2005) in patients with 
insomnia. For example, Mimeault and Morin (1999) found that telephone support 
can enhance the effects of the CBT-I self-help booklet in patients with primary 
insomnia but this extra effect disappeared at the 3-month follow-up. In contrast, 
another study found that CBT-I self-help, along with brief therapist telephone 
contact, improved the treatment effect in patients with comorbid insomnia (e.g. 
Jermelov et al., 2012). Another study found that a CBT-I self-help booklet with 
optional telephone support was effective among older patients (mean age 67 years) 
with various chronic health conditions and chronic insomnia (e.g. Morgan et al., 
2012). The results also showed a low use of telephone support during the 
intervention and no differences were found post-treatment between telephone 
support users and non-users. These results showed that telephone support might not 
improve treatment effects, although the authors stated that, without telephone 
support, participants might have less improvement (Morgan et al., 2012).  
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In sum, these studies highlight the potential effectiveness of CBT in the form of self-
help with minimal therapist support in patients with comorbid insomnia. Whereas, 
the current real world-based study goes a step further by indicating that CBT-I SH 
booklet also has the potential to be effective in clinical settings without the provision 
of professional support for patients with chronic health conditions and non-clinical 
sleep disturbance.  
In addition, the current study did not indicate that improved sleep is associated with a 
reduction in symptoms of anxiety and depression. These findings are not are not 
consistent with previous CBT-I SH booklet studies within the context of a clinical 
population in patients with cancer (e.g. Casault et al., 2015) and in patients with 
primary insomnia (e.g. Mimeault & Morin, 1999; van Straten et al., 2009; Morin et 
al., 2005) which found that CBT-I SH leads to a reduction in symptoms of anxiety 
and depression. Similarly, studies administrating group CBT-I to patients with cancer 
found that group CBT-I can reduce depressive symptoms (e.g. Quesnel et al., 2003; 
Savard et al., 2005) and anxiety symptoms (e.g. Savard et al., 2005). On the other 
hand, other CBT-I group studies did not show a significant reduction in anxiety 
symptoms in patients with cancer (e.g. Quesnel et al., 2003) or in patients with 
various chronic health conditions (e.g. Rybarczyck et al., 2002), nor a reduction in 
depression symptoms in patients with chronic pain (e.g. Currie et al., 2000).  
In general, there is some discrepancy in relation to the impact of CBT-I in reducing 
anxiety and depression symptoms among patients with insomnia or comorbid 
insomnia. Alternative explanations of there being no significant results in relation to 
anxiety and depression symptoms in this type of group of patients may be that 
anxiety and depression are more related to patients’ health conditions and not to 
sleep per se, since anxiety and depression are common symptoms among patients 
with chronic health conditions. Moreover, a brief CBT-I self-help booklet may not 
have a significant effect on participants who experience less severe (moderate) levels 
of anxiety and depression or moderate levels of depression and anxiety may not be a 
problem. Additionally, depression and anxiety may be more likely in individuals 
with greater disease severity or an uncertain prognosis (e.g. cancer).  
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Finally, another possible explanation may be the use of a different tool in assessing 
anxiety and depression, which might have had different results. For example, 
previous studies have commonly used STAI (Spielberger et al., 1970) to assess 
anxiety (e.g. Qunsnel et al., 2003), BDI (Beck et al., 1961) to measure depression 
outcome (e.g. Qunsnel et al., 2003; Currie et al., 2000) or the Hospital Anxiety and 
Depression Scale (HADS; Sigmond & Snaith, 1983) (e.g. Savard et al., 2005; 
Casault et al., 2015; van Straten et al., 2009), whereas the current study used DASS-
21 (Lovibond & Lovibond 1995). The DASS-21 measurement was selected for the 
current study, mainly because it assesses depression and anxiety as well as stress, 
which is the most common precipitating factor in insomnia (Morin, 1993).    
Therefore, it was important for the current study to assess whether significant 
improvements in sleep lead to a reduction in symptoms of stress.   
Despite the lack of significant pre-and-post intervention differences in depression 
and anxiety symptoms, participants following the intervention showed a significant 
reduction in stress levels. It may be argued that physiological changes caused by 
stress that can trigger or exacerbate sleep are more modifiable in comparison to more 
clinically significant mental health problems (e.g. depression and anxiety). 
Consequently, the current findings suggest that a brief CBT-I SH booklet may be 
effective in reducing moderate levels of arousal which, in turn, suggests that a brief 
CBT-I SH booklet may help patients become more relaxed and less over-reactive and 
may improve sleep patterns. However, only one study has assessed the effectiveness 
of a CBT-I self-help booklet in relation to perceived stress in daily life, and it 
similarly found that a CBT–I SH booklet with support is effective in reducing stress 
(as measured by the Perceived Stress Scale (PSS-10; Cohen, Kamarck, & 
Memelstein, 1983) in patients with comorbid insomnia (e.g. Jermelov et al., 2012). 
Also, the same study, when comparing the CBT-I SH booklet without therapist 
control with waiting list patients, did not show a significant reduction in stress. 
Accordingly, the current results of the study further contribute to evidence, which 
indicates that CBT-I without therapist support may significantly reduce stress in a 
non-clinical sleep disturbance population with chronic health conditions.   
 
 
	   76	  
As previously discussed, cognitions play a vital role maintaining sleep problems 
(Morin, 1993). The findings suggest that a CBT-I SH booklet can also be effective in 
reducing dysfunctional beliefs and attitudes about sleep. This finding is consistent 
with previous SH studies with clinical (e.g. Casault et al., 2015; Rybarczyck et al., 
2005; Jermelov et al., 2012; Rybarczyk et al., 2011) and non-clinical populations 
(e.g. Van Straten et al., 2009; Mimeault & Morin, 1999) where a CBT-I SH 
intervention was used. Also, the current findings, in relation to sleep-related 
dysfunctional beliefs, are in line with previous studies on delivering group CBT–I to 
clinical populations (e.g. Rybarczyck et al., 2002; Rybarczyck, et al. 2005; Kapella et 
al., 2011). 
Consequently, an important finding that adds further support to the selection of the 
multicomponent CBT-I intervention of the current study comes from Edinger et al. 
(2001) who assessed the specific effects of CBT-I on sleep-related dysfunctional 
beliefs. Specifically, Edinger et al. (2001) found that participants with primary 
insomnia, who received a multicomponent CBT-I, showed a greater reduction of 
sleep-related dysfunctional beliefs compared to participants who received 
progressive muscle relaxation or a placebo and these improvements were maintained 
over the long-term. Furthermore, these changes were associated with both subjective 
and objective measurements of insomnia symptoms in the CBT-I group (Edinger et 
al., 2001). Finally, the authors stated that CBT-I is a beneficial treatment compared 
to behavioural since it corrects specific sleep-related dysfunctional cognitions. 
Another study found that a CBT-I group showed higher improvement in 
dysfunctional beliefs and attitudes about sleep compared to a pharmacological group 
for insomnia and these reductions were associated with improved sleep maintenance 
at follow-up (Morin, Blais & Savard, 2002).  
Collectively, these findings indicate that any treatment that does not target cognitions 
might have an effect on dysfunctional beliefs. However, a CBT-I intervention 
directly targets dysfunctional cognitions, leading to greater reductions in sleep-
related dysfunctional beliefs. Accordingly, the above findings (e.g. Edinger et al., 
2001; Morin et al., 2002) may be related to the findings of the current study since the 
intervention directly addressed cognitions. Also, it may be argued that participants 
have learned to manage better negative sleep-related beliefs. Potentially, the 
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improvements in sleep outcomes may be related with the reduction of sleep-related 
dysfunctional beliefs.    
With regard to HRQoL, the findings suggest that the CBT-I booklet used for the 
current study does not have an effect on HRQoL (both mental and physical). 
Whereas, previous studies have shown that a CBT-I SH can improve the general 
population’s mental well-being as measured by SF-36, but not overall quality of life 
(e.g. van Straten et al., 2009). Also, other self-administrated CBT–I interventions on 
patients with cancer showed no improvements to global quality of life but significant 
improvement in cognitive functioning (e.g. Casault et al., 2015). On the other hand, 
other CBT-I group studies in older adults with various chronic health conditions 
found no significant difference to daytime functioning (e.g.Rybarczyk, et al., 2002; 
Rybarczyck, et al. 2005), whereas, a group–CBT based study of patients with cancer 
showed significant improvement to global quality of life (e.g. Savard et al., 2005).  
In sum, as with anxiety and depression, the findings with respect to HRQoL are 
mixed. The lack of significant improvement to HRQoL for the current population 
may be attributable in various ways. Firstly, HRQoL (both mental and physical 
components) might be related to the symptoms of their chronic health condition 
rather than to sleep. The sample of the current study was diverse with regard to the 
type of chronic health condition or it had multi-morbidity conditions, which might 
have affected the HRQoL. It is also possible that six-weeks was not long enough 
period for patients who have had sleep disturbance from two months to 40 years to 
show a measurable improvement in HRQoL. Therefore, for the current sample it 
might be possible that patients who experience sleep problems over long-term period 
may require a different or more intensive approach, such as the delivery of CBT for a 
longer-period, in order to show improvements to HRQoL. For example, as implied 
within the framework of Espie’s (2009) stepped care model for insomnia, individuals 
may progress to more intensive treatment over time.   
 
Overall, consistent with previous studies, the current findings suggest that CBT-I SH 
booklet without support can be effective in improving sleep in populations with non-
clinical sleep disturbance or subclinical insomnia and chronic health conditions. In 
addition, the current findings show a reduction in stress and sleep-related 
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dysfunctional beliefs. On the other hand, no significant improvements were found for 
depression, anxiety and health-related quality of life.  
The current study has provided significant implications for both research and clinical 
practice in sleep research. These are considered below.   
 
 
5.1. Study Implications both in research and clinical practice  
 
The current study has several research and clinical implications. The most significant 
implication of the current study, both in research and clinical practice, is the         
real-world perspective and approach of the current study towards sleep research, 
specifically in studying participants with non-clinical sleep disturbance and chronic 
health conditions, rather than comorbid insomnia among patients with chronic health 
conditions. Certainly, the unique approach of the current study, in relying on 
individuals with self-reported sleep disturbances and administrating a holistic 
intervention, proved beneficial to this group of participants. These findings suggest 
that a brief, cost-effective and timely intervention may prevent the development of 
more severe sleep disturbance problems for patients with chronic health conditions. 
Furthermore, the current study showed that sleep and stress improved, demonstrating 
that sleep disturbance may not be related to clinical indicators such as depression and 
anxiety. Overall, within the field of health psychology, the current study contributes 
by its novel approach towards sleep research.  
Additionally, in terms of research, the current study highlighted and addressed the 
gap in the existing literature by considering patients with chronic health conditions 
and non-clinical sleep disturbance since this group of individuals has been largely 
ignored in the existing literature. In particular, the current study showed that 
individuals with non-clinical sleep disturbance undeniably experience poor sleep 
quality, moderate severity of insomnia and the levels of their psychological 
symptoms differ from normal profiles, and it established that this group of 
participants warrants further evaluation and effective treatment. Hence, the current 
study added to and extended the current literature that CBT for sleep problems in the 
form of a self-help booklet without professional support is an effective treatment in 
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alleviating sleep problems, reducing stress and sleep-related dysfunctional beliefs for 
patients with non-clinical sleep disturbance or sub-clinical levels of insomnia.  
 
In terms of clinical practice, CBT for sleep in the form of a SH booklet can be an 
effective treatment and can be considered as a good first step approach (Espie, 2009) 
for treating patients with various chronic health conditions and non-clinical sleep 
disturbance, including also those with sub-clinical levels of sleeping difficulties. 
Specifically, the provision of CBT-I in the form of a SH booklet may be particularly 
useful in clinical settings since it may be regarded as a convenient, cost-effective and 
flexible approach as it can certainly reach a large number of patients with various 
functional difficulties. Also, it may be useful in clinical settings where CBT may not 
be a viable treatment option due to lack of trained therapists, time etc.   
Accordingly, the current study further suggests that a brief CBT-I SH booklet may be 
effective and may be easily implemented in clinical settings (e.g. outpatient clinics) 
with patients with various chronic health conditions and sleep-related problems.  
In addition, the evaluation at the end of the intervention showed participants’ 
satisfaction and approval of the treatment. For example, 50% of participants rated the 
intervention as good and 71.7% stated that they definitely or might recommend the 
published CBT-SH booklet to other patients with sleep-related problems.  
Overall, the current study contributes significantly to both clinical and research 
practice by viewing sleep from a real-world perspective and by further showing the 
effectiveness and applicability of a brief CBT intervention for sleep problems in the 
form of a self-help booklet among patients with non-clinical sleep disturbance or 
sub-clinical levels of insomnia.   
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5.2. Strengths and limitations  
 
5.2.1. Strengths   
 
An important strength of the current study is that it was carried out and implemented 
as close as possible to a real-world context of sleep rather than being implemented as 
a controlled sleep study (e.g. identifying or screening participants with insomnia 
prior to the delivery of the intervention). Specifically, we relied on individuals’ self-
report of sleep complaints/problems and without excluding any participants that did 
not meet the clinical cut-off score of the PSQI (e.g. 3 participants had a score of <5= 
good sleepers).  
The current real-world approach further adds and shows that an individual’s own 
perception of having sleep-related problems needs to be taken into account since the 
results showed that the majority had poor sleep quality, clinical insomnia and mean 
moderate levels of psychological symptoms (e.g. anxiety, depression and stress). 
However, with regard to individuals who do not meet the cut-off score criteria or did 
not show severe sleep problems, an early treatment on sleep may be particularly 
relevant and of benefit to those individuals experiencing milder and more severe 
sleep problems.  
Furthermore, the assessment measurements used in the current study are well 
validated and the measurements were completed and sent by post without any face-
to-face contact and with no professional support from the researcher throughout the 
intervention (e.g. without minimal therapist support). Accordingly, the 
methodological approach towards sleep within a real-world context and the inclusion 
criteria of the current study highlight the suitability of the brief CBT-I self-help 
booklet within clinical practice.  
Additionally, the current study was carried out within a clinical context.   
Specifically, the participants were recruited from two specialised outpatient clinics 
and health professionals confirmed the patients’ diagnosis prior to taking part in the 
study. The sample was relatively heterogeneous concerning the type of their chronic 
health condition and type of sleep problem. For example, patients were included in 
the study with various chronic health conditions (e.g. lupus, osteoarthritis, arthritis, 
chronic pain and IBS) and/or with multi-morbidity of conditions and different types 
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of sleep-related problems (e.g. included in the study if they self-reported sleep 
disturbance). Also, the current sample was heterogeneous with regard to the various 
degrees of sleep-related problems and psychological symptoms (normal, mild, 
moderate, anxiety, depression and stress symptoms). Consequently, the current study 
has a means to guarantee that the findings can be generalisable in clinical outpatients 
settings in patients with various chronic health conditions, different sleep-related 
problems and psychological symptoms.  
In sum, the current study was based on a real-world context and the inclusion criteria 
were liberal, which maximizes the generalisability of the current results. 
Despite its strengths, the current study admittedly has several limitations. These are 
further stated below.  
 
 
5.2.2. Limitations 
 
The first limitation concerns the repeated measures design of the current study, since 
there was there was no control group. Randomized controlled trial (RCT) is 
considered as the most robust scientific method for assessing the effectiveness of an 
intervention within health care (Akobeng, 2005). On the other hand, since repeated 
measures design uses the same participants in every condition (Shuttleworth, 2009), 
participants acted as their own control by using their pre-assessment intervention 
scores in order to deal with the lack of a control group.  
Another limitation is that it is unknown whether the effects of the treatment 
intervention were maintained in the long-term since the current study did not include 
follow-up assessments (e.g. 6-month, 12-month etc.).  
Furthermore, the current study did not reach the target sample size since there was a 
notable dropout rate (56%) at post-treatment follow-up assessment. Whereas the 
current sample size was adequate enough to show a significant difference, it was 
relatively small (n=49). The high attrition rate of the current study differs from 
previous studies in the related area of CBT-I self-administrated interventions since 
previous studies had much lower dropout rates. A reasonable explanation in relation 
to this might be that participants in the current study were recruited from a clinical 
context. Whereas previous studies recruited participants from the community using 
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various methods such as advertisements, media websites and memberships of 
mailing lists groups etc. (e.g. Mimeault & Morin, 1999; Jermelov et al., 2012; 
Rybarczyck et al., 2011). However, the dropout rate is not surprising for clinical 
based study since patients may have higher severity symptoms of their illness or be 
less motivated compared to patients recruited from the community. Another reason 
that might have influenced the dropout rate is that the current study required a high 
degree of commitment (e.g. eight weeks overall, including pre-and-post assessments 
and a 6-week intervention) that may be also be related to the methodological 
disadvantages of the repeated measures design (e.g. participants may become tired, 
which increases the likelihood of an elevated dropout rate) (Shuttleworth, 2009). 
Finally, another reasonable explanation might be the lack of support during the 
intervention, though, as we had a telephone contact reminder regarding the post-
assessments, it was possible to outline some reasons for the withdrawal of 
participants from the current study. For example, the reasons were mainly related to 
their chronic health condition (e.g. flare-up, hospitalisation, etc.) or due to a change 
of attitude towards the study, workload demands, family/work stressors or going 
away on holiday. Additionally, statistical analyses comparing participants who 
completed the study with those who did not further added that the dropout rate was 
not related to demographic characteristics or outcome measures between the two 
groups.  
In addition, since it was a real-world study and since the current study aimed to 
maximize generalisability, the sample was heterogeneous as discussed above with 
respect to the type of chronic health conditions and sleep-related problems. However, 
this makes it difficult to generalise the results since the sample was relatively small. 
Also, participants were not excluded from the study if they were taking sleep 
medication or were currently undertaking any psychological treatment. But it is 
worth noting that only three participants reported having sleep medication and only 
one participant reported using relaxation tapes. Besides, it was considered both 
unethical and unfeasible to control for other confounding variables (such as 
medication for their chronic health condition that might have had sleep improvement 
effects). Thus, it is not clear if the effects of the treatment were due to the CBT-I SH 
booklet effect or to medication in relation to their chronic health condition, or related 
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to improvements in the symptoms of their chronic health condition, which 
subsequently improved sleep.  
 
Furthermore, the majority of the sample had similar demographic characteristics that 
might limit the generalisability of the results. For example, the majority of the 
participants had a good to high educational level so one might consider that they had 
good literacy skills. Consequently, it is unknown whether a CBT-I SH booklet is 
effective for patients with a lower educational level. A statistical analysis showed 
that there was a difference between highly educated participants and poorly educated 
participants. Also, the sample of the current study had a female preponderance, 
probably because insomnia is more common among women than men (Morgan, 
Kucharczyck & Gregory, 2011). On the other hand, this reduces the generalisability 
of the study findings to men with chronic health conditions and sleep problems. 
Finally, since the majority of our sample were Scottish, there is no means to ensure 
that the current results may be representative of the clinical population in other 
countries since individuals from other countries may have different perceptions of 
their illness and/or treatment, and different demographic characteristics, any/all of 
which might affect the results.  
Overall, the current results are difficult to be generalised across a wider-variety of 
population. Collectively, these factors constrain the generalisability of findings and 
highlight the need for further research involving other clinical populations.  
 
Finally, an important aspect concerning the self-help approach is the adherence of 
the individual with the treatment. The intervention evaluation questionnaire and the 
diary frequency (e.g. the use of the self-help booklet) obtained from the participants 
after the completion of the treatment was beneficial in terms of evaluating 
participants’ approval of and satisfaction with the current treatment and confirming 
the use of the CBT SH booklet over a period of six weeks. However, since it was a 
multicomponent CBT SH booklet, it is not clear whether participants read all the 
treatment CBT SH booklet and/or which components were the most helpful for 
participants and which techniques participants might have followed and practiced. A 
more practical adherence logbook (e.g. “please state whether you followed sleep 
hygiene instructions,” etc.), and more in-depth analyses of participants’ perceptions 
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would be beneficial since it would enable an evaluation of which component was the 
most beneficial. For example, it may be argued that only one component in particular 
was particularly effective in patients with mild sleep difficulties that may underly the 
current findings.  
Overall, taking into account both its strengths and limitations, the current study 
provided insight for future studies in the related field. 
 
 
5.3. Future recommendations  
 
Further studies into the area are warranted to establish the relationship between 
psychological factors and non-clinical sleep disturbance in patients with chronic 
health conditions and to further examine the effectiveness of self-administrated CBT-
I for patients with non-clinical sleep disturbance with chronic health conditions. In 
particular, future studies with a diverse methodological design, e.g. study design, 
outcome measures (e.g. stress and maladaptive sleep habits), different groups of 
patients with chronic health conditions, long-term follow up and larger sample sizes, 
with diverse sleep problems. For example, with regard to study outcomes, it is noted 
in the literature that stress is the most common precipitating factor for sleep 
problems and other factors maintaining sleep include maladaptive sleep–habits and 
sleep-related dysfunctional beliefs (Morin, 1993). The current study assessed stress 
but there is limited evidence in the existing literature for further addressing this 
factor as well as maladaptive sleep habits. Therefore, future studies with diverse 
methodological methods, larger sample size and randomized experimental design 
should aim to examine whether CBT has an effect on such outcomes in order to 
provide robust evidence of the effectiveness of CBT for sleep-related problems in 
patients with chronic health conditions. 
It would also be beneficial to further examine whether therapist support is essential 
for patients with various chronic health conditions and non-clinical sleep 
disturbance, including individuals with sub-clinical sleep difficulties, since the data 
from previous studies on patients with primary or comorbid insomnia is still 
inconclusive. For example, future studies need to examine the effectiveness of CBT-I 
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self-help with therapist support vs. without it, as well as the adherence levels of 
participants to the intervention with and without therapist support. 
Furthermore, it may be possible that non-compulsory contact support might have an 
impact on participants’ adherence and/or increase participants’ motivation towards 
the intervention. Moreover, it might be a helpful alternative approach for individuals 
who need support throughout the intervention.  
Future studies may further evaluate whether all the components of CBT–I are 
essential and which are the most beneficial techniques for patients with chronic 
health conditions, either with non-clinical sleep disturbance or sub-clinical sleep 
difficulties. For example, such studies may tailor the intervention treatment content 
to patients’ characteristics or needs (e.g. for highly anxious participants, progressive 
muscle relaxation might be an appropriate technique). Future studies can further 
examine participants’ characteristics to show who benefits and who does not benefit 
from a multicomponent CBT-I. Additionally, future research is needed to examine 
which component is the most effective by comparing different behavioural 
interventions for sleep-related problems in patients with chronic health conditions. 
Also, it is reasonable to argue that CBT-I SH may be a cost-effective approach since 
it requires fewer resources (e.g. less specialist time or without therapist support). 
Since insomnia is associated with high costs, it is important to provide an effective 
and low-cost treatment, despite the severity of the sleep problem, and also to further 
examine the cost-effectiveness of such interventions within healthcare.  
Furthermore, Internet-based treatment is a novel and promising mode of delivering 
CBT-I (Espie, 2009) since it has become widely accessible to the public with an 
increasing number of people using it nowadays. Several recent studies have shown 
the effectiveness of Internet-delivered CBT-I in a non-clinical population (e.g. Espie, 
Kyle, Williams et al., 2012; Ritterband et al., 2009; Strom, Pettersson & Anderson et 
2004) and in patients with psychiatric conditions and sleep problems (e.g. Vincent & 
Lewysky, 2009). The Internet might be considered a more favourable method of 
delivering such interventions to individuals that are computer literate and would 
perhaps find it preferable. Consequently, for future studies interested in 
administrating a CBT–I intervention through Internet-based platforms, it would be 
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beneficial, prior to the implementation of the study, to assess the needs of the current 
population (i.e. a pilot study before the implementation of the intervention). 
 
 
5.4. Summary and Conclusion  
 
The current study highlights and demonstrates that patients with non-clinical sleep 
disturbance deserve early, brief and effective treatment for sleep-related problems. 
Within its limitations and strengths, the current study shows that CBT-I in the form 
of a self-help booklet, can improve sleep quality, reduce insomnia symptoms as well 
as related sleep related-dysfunctional beliefs and stress symptoms in this relatively 
heterogeneous clinical sample with non-clinical or sub-clinical sleep difficulties. 
However, the present results suggest that CBT-I self-help booklet is not effective in 
reducing anxiety and depression symptoms and improving health-related quality of 
life. 
In terms of its implementation, CBT-I self-help intervention in the form of a booklet 
can be considered as a practical treatment intervention as it is easily administrated, 
relatively inexpensive (e.g. fewer resources), not time-consuming either for health 
professionals or patients, it can be easily delivered and can also benefit a wide range 
of the population. Overall, a brief CBT-I self-help booklet is effective for patients 
with chronic health conditions and non-clinical sleep disturbance in clinical settings.   
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